- ispad 2010

Transcription

- ispad 2010

October 27th – 30th, 2010 | Buenos Aires, Argentina
36th Annual Meeting
International Society for Pediatric and Adolescent Diabetes
ISPAD 2010
Conference Program
October 27th – 30th, 2010
Buenos Aires, Argentina
Progress in
Pediatric Diabetes
http://2010.ispad.org
1
36th Annual Meeting | International Society for Pediatric and Adolescent Diabetes
NovoRapid®: no other
rapid-acting insulin is
part of so many lives2
The most prescribed rapidacting insulin worldwide,2
backed by over a decade
of clinical use 1
Approved for every stage of life,
from children aged 2 years to
the elderly 1
Helps patients attain and
maintain their HbA1c goals3
Pre- and post-meal dosing
allows patients to treat
according to lifestyle 4
2
NovoRapid ® Insulin aspart
NovoRapid ® Penfill® 3 ml. NovoRapid ® FlexPen® 3 ml. All
presentations contain insulin aspart 100 units/ml. Indication:
Treatment of diabetes mellitus in adults and adolescents and
children aged 2 to 17 years. Dosage and administration:
Individual by subcutaneous injection usually between 0.5 and
1.0 U/kg/day. It should normally be used in combination with
intermediate or long-acting insulin given at least once a day.
NovoRapid ® has a faster onset and a shorter duration of action
than soluble human insulin and should generally be given
immediately before a meal. When necessary NovoRapid ® can be
given soon after a meal. Blood glucose monitoring and dose
adjustments are recommended to achieve optimal glycaemic
control. In elderly patients and patients with renal or hepatic
impairment, glucose monitoring should be intensified and insulin
aspart dosage adjusted on an individual basis. No studies in
children under the age of 2 years; should only be used in this age
group under careful medical supervision. Can be used in children
in preference to soluble insulin when a fast onset of action might
be beneficial. Transfer from other insulin products may require
adjustment of the NovoRapid ® or basal dose. May also be used
in a suitable pump system for continuous subcutaneous insulin
infusion. If necessary, may be administered intravenously by a
healthcare professional. Contraindications: Hypersensitivity to
active substance or excipients. Special warnings and special
precautions: Travelling between different time zones may
change the time of when to take the insulin if meals are at
different times. Inadequate dosing or discontinuation of
treatment may lead to hyperglycaemia and diabetic ketoacidosis,
which is potentially lethal. Omission of a meal, unplanned
strenuous physical exercise or too high a dose in relation to
insulin requirements may lead to hypoglycaemia. Patients whose
blood glucose control is greatly improved may experience a
change in their usual warning symptoms of hypoglycaemia.
Usual warning symptoms may disappear in patients with
longstanding diabetes. If hypoglycaemia occurs, it may occur
earlier after an injection compared with soluble human insulin.
The fast onset of action should be considered in patients where
a delayed absorption of food might be expected. Changes in
early warning symptoms of hypoglycaemia may occur on transfer
between different types of insulin products. Transferring to
another type or brand of insulin should be done under strict
medical supervision. Patients transferred to NovoRapid ® from
another type of insulin may require an increased number of daily
injections or a change in dosage. Injection site reactions, usually
transitory, may occur; rotation of injection sites within an area
may help reduce or prevent these reactions. Rarely, injection site
reactions may require discontinuation of NovoRapid ®.
Hypoglycaemia may constitute a risk when driving or operating
machinery. NovoRapid ® must not be mixed with other medicinal
products except for NPH (Neutral Protamine Hagedorn) insulin
and some infusion fluids. Consult Summary of Product
Characteristics for details. Pregnancy and lactation: NovoRapid®
can be used in pregnancy. No restrictions on use during breastfeeding. Undesirable effects: Hypoglycaemia is the most
frequently occurring side effect. Very common (≥1/10); common
(≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare
(≥1/10,000 to <1/1,000); very rare (<1/10,000), not known
(cannot be estimated from the available data). Uncommon:
Refraction disorders (usually transitory in nature), worsening of
diabetic retinopathy, lipodystrophy, local hypersensitivity
reactions; oedema upon initiation of insulin therapy, urticaria,
rash and eruptions, Rare: Peripheral neuropathy – acute painful
neuropathy; Very rare: Anaphylatic reactions. The Summary of
Product Characteristics should be consulted for a full list of side
effects. Prescription-only medicine. Novo Nordisk A/S,
Novo Allé, DK-2880 Bagsværd, Denmark. Text last revised:
December 2009. Summary of Product Characteristics can be
obtained from Novo Nordisk.
APROM ID#2257; approval date: August 2010
In Argentina approved by ANMAT Certificate N°48.419
Disp. 1091/10
References: 1. NovoRapid ® Summary of Product Characteristics.
2. IMS Health Inc. IMS MIDAS (MATQ2’09). 3. Holman RR et al.
for the 4-T Study Group. Three-year efficacy of complex insulin
regimens in type 2 diabetes. N Engl J Med. 2009; 361(18):
1736–1747. 4. Brunner GA et al. Post-prandial administration
of the insulin analogue insulin aspart in patients with type 1
diabetes mellitus. Diabet Med. 2000; 17(5): 371–375.
Table of Contents & Corporate Sponsors
Table of Contents
Corporate Sponsors......................................3
Welcome Messages................................ 4‒5
About ISPAD.................................................... 6
Key Facts............................................................7
Conference Information......................8‒9
Scientific Program Overview...........10‒11
Scientific Program - Wednesday.... 12‒16
Scientific Program - Thursday......... 17‒19
Scientific Program - Friday..............20‒25
Scientific Program - Saturday........ 26‒27
Posters......................................................28‒42
Conference Venue
& Exhibition Plan....................................... 43
Social Events / Tours.................................46
City & Hotel Map....................................... 47
Corporate Sponsors
ISPAD and the organizers would like to thank the following sponsors and exhibitors
PLATINUM SPONSORS
GOLD SPONSORS
GENERAL SPONSORS
3
Welcome Message
Welcome Message from the Conference President
Dear Friends,
The city of Buenos Aires has much to celebrate in October 2010. Not only will it receive the
participants of the 36th ISPAD Annual Meeting, but it will be the first ISPAD Meeting to be
held in Latin America. In 2010 Argentina is celebrating its 200th anniversary as an independent state, and the whole country will be enjoying the lovely southern hemisphere’s spring
season. Argentina and Latin America are very proud that Buenos Aires has been chosen as
the venue for this Meeting.
Prestigious speakers are coming from all over the world, from both emerging and first
world countries, creating an atmosphere of understanding. Two hemispheres will be
working together and sharing their knowledge and experiences helping us to comprehend
different realities. It is our desire that not only information, but also cultures will interact to
bring better understanding among us.
We hope all nations to be present, and we also hope that you can find a relaxed atmosphere
that Buenos Aires and the presence of Latin American affection can bring you.
The Scientific Programme will provide great opportunities to learn and discuss new information concerning diagnostic and therapeutic developments as well as cutting edge data
in several fields of diabetes research and care: new and exciting advances in the fields of
prevention and management of diabetes and all its interrelated factors.
Olga Ramos
Conference President
Another fundamental aspect that makes this meeting unique is that it will have simultaneous English - Spanish translation thanks to the kindness of the whole Assembly, a kindness
all the Spanish speaking community really appreciates as it allows them to share opinions more smoothly. As this will be a multidisciplinary meeting for pediatricians, nurses,
nutritionists, psychologists and other members of the health group, they will all have the
opportunity of attending general and special sessions.
Optimal diabetes care requires an integral approach and an active collaboration between
all health professionals. This partnership will enable us to meet our common goal: to enhance the lives of children and adolescents with diabetes.
Buenos Aires is waiting for you!
On behalf of the Organizing Committee
Yours sincerely,
4
Welcome Message
Welcome Message from the ISPAD President
Dear Friends and Colleagues,
It gives me great pleasure to invite you to our 36th Meeting of the International Society for
Pediatric and Adolescent Diabetes which will take place in the city of Buenos Aires. This is
the first time an ISPAD meeting is held in Latin America.
Almost 6% of the adult population - or more than 18 million people - suffer from diabetes in
Latin America. Despite these alarming adult numbers it is important to put the spotlight on
the most vulnerable population: the children which are affected with all forms of diabetes
in increasing numbers as well. European data published in 2009 indicate if present trends
continue, doubling of new cases of type 1 diabetes in children younger than 5 years is
predicted between 2005 and 2020, and prevalent cases younger than 15 years will rise by
70%. Thus, adequate health care resources to meet these children’s needs should be made
available around the world.
“Progress in Pediatric Diabetes: from Vision to Reality” is the theme of this years conference.
The evidence is growing that we are making significant advances in achieving better and
better outcomes. The treatment options for young people with diabetes are better than
they have ever been and visions of even superior approaches are at our fingertips. However,
the reality is that too many children with diabetes have insufficient access to adequate
care or adopt behaviors which, in the long term, will reduce their ability to lead healthy and
productive lives.
Thomas Danne
ISPAD President
Historically, Buenos Aires has been Argentina‘s main venue for liberal and free-trade ideas.
Without doubt the “fair winds” giving the name to this town will be an ideal surrounding
for our discussions on how to close the gap between our visions of a bright future for children
with diabetes and the sometimes harsh realities of modern day health care.
We would like to highlight the fact that although all the speakers will present in English,
there will be English/Spanish, simultaneous translation, which will enable the discussion
and conclusions in both languages. It is a great opportunity for all Latin Americans to put
forward their ideas to the international ISPAD family.
I look forward to meeting you in Buenos Aires and experiencing a most exciting and inspiring
36th Annual ISPAD Meeting in the Argentinean tradition of hospitality, excellent food and
drink, tango music and other cultural delights.
5
About ISPAD
About ISPAD
ISPAD Prizes
The Society
ISPAD is a professional organization whose aims are to promote clinical and basic science, education and advocacy in
childhood and adolescent diabetes. The strength of ISPAD lies
in the scientific and clinical expertise in childhood and adolescent diabetes of its members. ISPAD is the only international society focusing specifically on all types of childhood
diabetes.
ISPAD Best Oral / Poster Prize
The ISPAD Best Oral Prize and also the ISPAD Best Poster Prize
will be given to any individual (ISPAD Member and NonMember) submitting an abstract to the 36th Annual Meeting
International Society for Pediatric and Adolescent Diabetes.
The papers will be judged and ranked by the Reviewing Committee. The best poster and oral presentation will be chosen
at the meeting by the Prize Committee under the auspices of
the ISPAD Steering Committee.
ISPAD Steering Committee
Thomas Danne Lynda K. Fisher Stuart Brink
Ragnar Hanås Kenneth J. Robertson ISPAD Prize for Achievement
Sponsored by Eli Lilly and Company
The ISPAD Prize for Achievement is the society’s highest
honor. It is awarded to any individual who has made outstanding contributions in the areas of science, education or
advocacy which have had a major impact on childhood and
adolescent diabetes.
ISPAD Advisory Council
Maria Craig Marie C. Hallman Lori M.B. Laffel
Wojciech Mlynarski
Kubendran Pillay Aman Pulungan Neil H. White
Tim Wysocki
President
President-Elect
Immediate Past President
Secretary General
Treasurer
Officer
Officer
Officer
Officer
Officer
Officer
Officer
Officer
ISPAD Young Investigator Award
Sponsored by Medtronic
Any ISPAD Member (aged 40 or less) can apply for the ISPAD
Young Investigator Award. The application must include a
paper published in a peer reviewed journal within two years
prior to application. The award also includes a fifteen minute
presentation during the “Young Investigator Lecture”
ISPAD Lestradet Award for Education and Advocacy
Sponsored by LifeScan
The ISPAD Lestradet Prize for Education and Advocacy will be
given to honor any nominee (ISPAD Member) who has made
an outstanding contribution within education and advocacy.
The beneficiary will hold a thirty minute talk during the
“Lestradet Lecture”
Find out more about ISPAD at www.ispad.org
6
ISPAD Prize for Innovation in Pediatric Diabetes Care
Sponsored by NovoNordisk within their DAWN Youth Initiative
This prize is for any professional, group or individual who has
made a significant innovation in pediatric diabetes care.
DAWN Youth is a global program to guide the wider diabetes
community to address the unmet needs of young people
with diabetes, their families, peers and healthcare professionals. This prize puts the focus on diabetes in childhood
by recognizing innovations to improve health and quality of
care for children and young people.
Key Facts
Committees
Contacts
Local Organizing Committee
Lucila Agnese, MD, Buenos Aires
Susana Barbeito, MD, Buenos Aires
Pablo Duran, MD, Buenos Aires
Mabel Ferraro, MD, Buenos Aires
Alejandra Franchello, RD Dietitian, Buenos Aires
Maria Emilia Mazzei, RD Dietitian, Buenos Aires
Gloria Montagna, MD, Salta
Marta Ropolo, MD, Cordoba
Conference President
Olga Ramos, MD
Hospital General de Niños P. de Elizalde
Juncal 840 3° A (C1062ABF)
Abstract Reviewing Committee
Silvia Asenjo
Chile
Luis Castaño
Spain
Sukran Darcan
Turkey
Carine de Beaufort
Luxembourg
Alan Delamater
United States
Harry Dorchy
Belgium
Pablo Duran
Argentina
Mabel Ferraro
Argentina
Damla Göksen
Turkey
Ragnar Hanås
Sweden
Olga Kordonouri
Germany
Ingrid Libman
United States
Renata Lorini
Italy
María Emilia Mazzei
Argentina
Margaret McGill
Australia
Olga Ramos
Argentina
Jean-Jacques Robert
France
Maria Isabel Rojas
Perú
Peter Swift
United Kingdom
Conference Secretariat
K.I.T. Group GmbH
Association & Conference Management
Kurfürstendamm 71
10709 Berlin, Germany
Tel.: +49 30 24603-210
Fax.: +49 30 24603-200
ispad2010@kit-group.org
Local Secretariat
For transfer bookings please contact:
Maria Graziani & Asociados
Carlos Pellegrini 979 6º 22 (C1009ABS)
Tel.: +54 11 43933-437
congresos@mariagraziani.com
Conference Venue
Sheraton Buenos Aires Hotel & Convention Center
San Martin 1225/1275 (C1104AKC)
7
Conference Information
Abstract Book
The Abstract Book is published as a supplement to Pediatric
Diabetes. It will be distributed onsite to all participants.
Abstract CD
The Abstract CD, sponsored by Roche, will be available at the
Roche booth. Vouchers can be found on the badge letters.
Exhibition
Conference participants are invited to visit the exhibition in
the foyer of the Sheraton Buenos Aires Hotel & Convention
Center. The exhibition will be open during the following
times:
Wednesday, October 27, 2010................................... 07.30 – 20.00
Thursday, October 28, 2010........................................ 07.30 – 14.00
Certificate of Attendance
The Certificate of Attendance, sponsored by Eli Lilly and
Company, will be available at the Eli Lilly and Company
booth. The voucher can be found on the badge letters.
Continued Medical Education
ISPAD 2010 is accredited with UEMS for a total of 18 CME credits.
The Certificate of Attendance serves as proof of attendance and
can be used to apply for credits with local authorities.
EACCME Statement
ISPAD 2010 is accredited by the European Accreditation
Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The
EACCME is an institution of the European Union of Medical
Specialists, www.uems.net. ISPAD is designated for a maximum of 18 hours of European external CME credits. Each
medical specialist should claim only those hours of credit
that he/she actually spent in educational activity. EACCME
credits are recognized by the American Medical Association
towards the Physician’s Records Award (PRA). To convert
EACCME credit to AMA PRA category 1 credits, contact the
AMA.
Conference Bag
The conference bag, containing the conference material, can
be obtained in the registration area at the conference venue.
Currency
The national currency in Argentina is Argentine peso (ARS, $)
but all payments connected with the ISPAD 2010 conference
will be in Euro (€). Credit cards (Visa/Mastercard/Diners/
Amex) are accepted as well.
Friday, October 29, 2010............................................... 07.30 – 17.30
Saturday, October 30, 2010......................................... 08.00 – 14.00
Filming and Taking Pictures
Out of respect for author’s and speaker’s copyrights, it is
forbidden to take pictures and/or to film during any official
conference sessions. In case of negligence, the organizers
reserve the right to exclude the participant from the
conference.
Insurance and Liability
The conference organizer, the International Society for
Pediatric and Adolescent Diabetes and the ISPAD Conference
Secretariat cannot accept liability for personal injury, loss of
or damage to belongings of conference participants, either
during or as a result of the conference. Please check the validity
of your own insurance.
Internet
Internet stations will be available in the exhibition area.
ISPAD Service Point
The Society will have a service point in the exhibition area
where members can ask questions, pay their fees, etc. NonMembers are also invited to learn more about ISPAD.
As the service point for ISPAD members will have opening
hours, you can also contact a staff at the registration counter
for more information.
Please come to the ISPAD Service Point to find out more
about DIAMAX: mini which has been developed for all diabetes
specialists that do not use an electronic health record yet and
want to start electronic documentation on a limited scale!
Language
The official conference language is English. Simultaneous
translation will be provided from English to Spanish for the
Plenary Sessions.
8
Lost/ Forgotten Name Badge
In case you forget to bring your name badge/voucher letter
to the conference, a credit card guarantee for the total
amount of the registration fee will be required to get a
replacement badge. In addition, a non-refundable handling
fee of € 30 will be charged. Your old name badge will be
de-activated and become invalid. To release the credit card
guarantee and avoid double payment, the complete and
undamaged original letter has to be sent to the conference
secretariat within four weeks after the conference. If a
delegate loses or misplaces his name badge, a handling fee
of € 30 will be charged for a new name badge. Your old name
badge will be de-activated and become invalid. Kindly note
that vouchers for the Social Program are not substitutable.
Mobile Phones
Mobile phones must be set to silent mode in all session
rooms at all times.
Name Badge
A badge is required for admittance to all official conference
sessions and events. Each participant is asked to present the
badge in order to gain access to the conference. The name
badge must be worn and clearly displayed at all times.
Poster Area / Poster Sessions
The poster area will be located in room Retiro on the first floor.
The posters will be present during the entire conference. Poster
Sessions with a designated chairman will take place at the
times indicated in the program. All poster presenters are asked
to post their posters well before this time and to be present
during the times of presentation. Material and the exact
location of where to attach the posters to the poster walls will be
provided.
Program Changes
The organizers cannot assume liability for any changes in the
program due to external or unforeseen circumstances. Please
check the website for regular updates. The organizers reserve the
right to cancel, postpone, relocate or change any of the sessions.
Registration
Please bring this confirmation to the conference venue and
go directly to the Self Printing Stations. The barcode on this
document will allow you to print your conference name
badge. You can then pick up your conference material in the
registration Area.
The registration desks are open during the following times:
Tuesday, October 26....................................................... 15.00 – 18.00
Wednesday, October 27................................................ 06.30 – 18.00
Thursday, October 28..................................................... 06.30 – 15.00
Friday, October 29 .......................................................... 06.30 – 16.30
Saturday, October 30 ..................................................... 07.00 – 12.00
Smoking Policy
It is forbidden to smoke in any part of the conference venue.
Speakers Center
Invited speakers, chairmen and oral abstract presenters must
report to the Speakers’ Center, located on the second floor,
room Gómez Losada (E), at least four hours prior to their
presentation in order to check and deposit their presentation.
Please provide the data on a USB Memory Stick or a CD-ROM.
Please note that it is not allowed to run the presentation
from your personal laptop in the session room. Video support
is at the sole responsibility of the speaker. The opening hours
of the speakers’ center are the same as registration opening
hours.
Tours
To book a tour or for questions about tours, please visit the
counter “Tours / Hotel” in the registration area.
Transfers
For transfers to and from Social Program locations, please
check the Social Program section for details.
9
Scientific Program
Wednesday, October 27th
Thursday, October 28th
07.00
Breakfast Symposium Breakfast Workshop I
08.00
Breakfast Symposium
Exclusive Breakfast Symposium
Application of Technology for Better Diabetes Management
CareLinkTM Workshop
Solving the Puzzle of Diabetes
with CareLinkTM Therapy
Management Software
Medtronic
Roche
Break
Eli Lilly and Company
Medtronic
09.00
Advances in the
Understanding and
Treatment of Type 1 Diabetes
Advanced technologies for
children and adolescents
with diabetes: Do our
patients really benefit?
Plenary Session III
Emerging Trends in Obesity Research
Break
10.00
Opening Session:
Absence of Chronic Complications in
Youth - Vision or Reality?
Break
11.00
Plenary Session I
A Difficult Start: The Pregnant Adolescent
with Type 1 Diabetes Mellitus
12.00
Symposium I
Bad Visions:
Substance Abuse in
Youngsters with Diabetes
Symposium II
The Loop Club:
Is Closing it Near Reality?
Break
iPro(tm)2 Professional CGM : Integrating the
latest retrospective CGM Device into Clinical
Practice
Lunch Workshop I
Break
13.00
Medtronic
Poster Session
14.00
15.00
Symposium III
The View from the
Beta-Cell: A Cure in Sight?
Symposium IV
Looking Healthy:
Exercise and Diabetes
Plenary Session II
Avoiding Real Problems: The Threat of DKA
16.00
Break
17.00
Oral Session I
New Approaches
in Chronic
Complications
Oral Session II
Novel Findings in
Pediatric Diabetes
Management
Oral Session III
Recent
Results in the
Epidemiology
of Childhood
Diabetes
Social Afternoon
Opera Pampa
18.00
Break
19.00
Opening Ceremony
20.00
Welcome Reception
10
Scientific Program
Friday, October 29th
Saturday, October 30th
07.00
Breakfast Symposium
Breakfast Workshop II
Challenges Across the Biological and
Psycho-social Spectrum: Optimizing Safety &
Quality of Life within Pediatric Diabetes Care
CareLinkTM Workshop
Solving the Puzzle of Diabetes with
CareLinkTM Therapy Management Software
Novo Nordisk
Medtronic
08.00
Break
09.00
Plenary Session IV
Real Numbers:
Data Bases for Pediatric Diabetes Research
Plenary Session V
On the Lookout for the Right Target:
The Current Situation of Diabetes Prevention
Break
Break
Oral Session IV
Psychosocial
Issues &
Education in
Diabetic Youth
Oral Session V
Unraveling the
Genetic Basis
of Diabetes in
Children
Oral Session VI
Update in
Clinical Care
of Pediatric
Diabetes
Lunch Workshop II
iProTM 2 Professional CGM : Integrating
the latest retrospective CGM Device into
Clinical Practice
Break
Medtronic
Symposium V
Ethical Viewpoint:
What are the Limits
of Pharmacological
Intervention in the
Paediatric Patients with DM?
10.00
11.00
Symposium VI
Looking at the Genes New Insights
12.00
Closing Ceremony
13.00
Farewell
Poster Session
Symposium VII
New Approaches to
Diabetes Psychology for
the Real World
14.00
Symposium VIII
Early Complications:
A Nutritional View
15.00
16.00
Break
ISPAD Annual Assembly
(for members only)
17.00
Post Conference Tours
(optional)
18.00
19.00
Society‘s Evening
with Award Ceremony
Palacio San Miguel
20.00
11
Scientific Program
Wednesday, October 27
08.00 - 09.30
Exclusive Breakfast Symposium: Medtronic
Libertador B/C
Application of Technology for Better Diabetes Management
Chair: Thomas Danne (Germany)
Utilization and Benefits of iProTM2 - Professional CGM
Orit Pinhas-Hamiel (Israel)
Latest Clinical Data
Fran Kaufman (United States)
Optimising the Use of Insulin Pumps
Birthe Olsen (Denmark)
10.00 - 11.00
Opening Session:
Libertador B/C
Absence of Chronic Complications in Youth - Vision or Reality?
Chairs: Olga Ramos (Argentina) , Stuart Brink (United States)
Introduction
Olga Ramos (Argentina)
Opening Remarks
Thomas Danne (Germany)
Epigenetic Changes Associated with the Legacy of Hyperglycemic Memory
Sam El-Osta (Australia)
Early Prevention of Macrovascular Disease - Reason for Optimism?
Knut Dahl-Jorgensen (Norway)
11.00 - 12.30
Plenary Session I:
Libertador B/C
ALAD@ISPAD Symposium - A Difficult Start: The Pregnant Adolescent with Type 1
Diabetes Mellitus
Chairs: Rasa Verkauskiene (Lithuania), Tatsuhiko Urakami (Japan)
Puberty, Ovarian Function and Pregancy in Adolescent with Diabetes
Ethel Codner (Chile)
Impact of PPAR Natural Agonists on the Prevention of Diabetic Embryopathy
Alicia Jawerbaum (Argentina)
12
Scientific Program
Impact of Maternal Nutrition on the Short- and Long-Term Offspring Outcome
Emilio Herrera (Spain)
Poster Sessions:
13.30 - 14.30
Please see the poster section for details.
Plenary Session II:
Avoiding Real Problems: The Threat of DKA
Retiro
14.30 - 16.00
Libertador B/C
Chairs: María Isabel Rojas (Peru), Ragnar Hanås (Sweden)
Cerebral Edema and DKA- Epidemiology and Pathogenesis
Julie A. Edge (United Kingdom)
Minimizing the Risk of Cerebral Edema in DKA
Desmond Bohn (Canada)
Cerebral Edema: Risk Factors in Latin America
Mabel Ferraro (Argentina)
Oral Session I:
16.30 - 18.00
New Approaches in Chronic Complications
Libertador A
Chairs: Paul Benitez (Australia), Lynda Fisher (United States)
O/1/WED/01
Assessment of Tissue Glycation by Measurement of Plantar Fascia Thickness in
Children and Adolescents with Type 1 Diabetes
M.A.K. Salem, S.M. Farid, I.M. Rassem, M.A.H. Ahmed
O/1/WED/02
Ocular Surface Disorders in Children and Adolescents with Type 1 Diabetes
Mellitus
M.A. Salem, A.A.-F. El-Shazly, A.A. Abdelmaksoud, A.S. Shalash, E. Abdelmohsen
O/1/WED/03
Risk Factors for Sensitive and Motor Polyneuropathy in Type 1 Diabetes
A. Tilmanne, C. Mélot, P. Deltenre, H. Dorchy
13
Scientific Program
O/1/WED/04
Reduction of Endothelial Progenitor Cells and Poor Glycemic Control are
Predictors for Microvascular and Macrovascular Aberrations in Type 1 Diabetic
(T1D) Children within Three Years
M.J. Fritsch, K. Nagl, T. Hoertenhuber, E. Schober, O. Schlager, M.E. Gschwandtner,
A. Willfort-Ehringer, C. Margeta, R. Koppensteiner, G. Schernthaner, B. Rami,
G.-H. Schernthaner
O/1/WED/05
Evidence for Early Stage Atherosclerosis and Low Grade Inflammation in Diabetic
Children on Intensive Insulin Treatment: a Population Based Study.
H.D. Margeirsdottir, K.H. Stensaeth, I. Seljeflot, H. Arnesen, J.R. Larssen, C. Brunborg,
S.J. Kummernes, K. Dahl-Jørgensen,
O/1/WED/07
Longitudinal Study of the Endothelial Function in Children and Adolescents
Affected by Type 1 Diabetes Mellitus
L. Iughetti, R. Rossi, B. Predieri, A. Nuzzo, P. Bruzzi, A. Salvini, V. Patianna,
G. Delle Donne, M.G. Modena
O/1/WED/08
Changes in Forearm Vascular Resistance (Fvr) Caused by Hyperglycemia-induced
Vasodilation in Adolescents with Type 1 Diabetes
A. Dye, R. Hoffman
16.30 - 18.00
Oral Session II:
Libertador B
Novel Findings in Pediatric Diabetes Management
Chairs: Stefano Zucchini (Italy), Martin Borkenstein (Austria)
O/2/WED/01
Recombinant IGF-1 Treatment Induced-retinopathy in a Youth with Severe
Insulin Resistance Syndrome
E. Bismuth, M. Autié, N. Tubiana-Rufi, P. Massin, J.-C. Carel
O/2/WED/02
Urinary C-peptide Creatinine Ratio is a Possible Novel Non Invasive Alternative to
the Inpatient Mixed Meal Tolerance Test in Children with Type 1 Diabetes
R.E.J. Besser, A.T. Hattersley, T. Mcdonald, J. Ludvigsson
14
Scientific Program
O/2/WED/03
Clinical and Hormonal Profile in Adolescent Girls with Type 1 Diabetes Mellitus
and Polycystic Ovary Syndrome or Polycystic Ovary Morphology
G. Deja, A. Zachurzok-Buczynska, A. Gawlik, E. Malecka-Tendera
O/2/WED/04
Type 2 Diabetes and Mody Prevalence in a Belgian Diabetic Cohort
T. Mouraux, H. Dorchy
O/2/WED/05
Relationship Between Insulin Reserve and Weight Gain in Children With T1aDM
I. Libman, M. Cedillo, V. Arena, M. Pietropaolo, D. Ize-Ludlow, D. Becker
O/2/WED/06
Effect of GAD-alum Treatment in Type 1 Diabetic Children: 4 Years Follow –up
J. Ludvigsson, M. Hjorth, M. Chéramy, S. Axelsson, M. Pihl, R. Casas
O/2/WED/07
Younger Age at Diabetes Diagnosis Increases Risk of Coeliac Disease
A. Pham, K.C. Donaghue, A. Chan, M.E. Craig,
O/2/WED/08
Effect of Physical Exercise on Bone Density and Remodeling in Egyptian Type 1
Diabetic Osteopenic Adolescents
S.A. Elhabashy, Omaima Mohamed Said, Mervat Harvi Agaiby, Amr A Abdelrazek,
And Sayed Abdelhamid
Oral Session III:
16.30 - 18.00
Recent Results in the Epidemiology of Childhood Diabetes
Libertador C
Chairs: Paul Wadwa (United States), Elise Bismuth (France)
O/3/WED/01
First Trimester Cytokine Levels in Mothers to Children Diagnosed with Islet
Autoimmunity or Type 1 Diabetes Before Eight Years of Age
S. Resic Lindehammer, M. Fex, K. Marsal, Å. Lernmark, Diabetes Prediction In Skåne
(Dipis) Study
O/3/WED/02
Changing Pattern in Incidence of Type 1 Diabetes in Hungarian Children Over 1989-2008
E.K. Gyurus, G. Soltesz, Hungarian Childhood Diabetes Epidemiology Group
15
Scientific Program
O/3/WED/03
Growth Differences Between North American and European Children at Risk
for Type 1 Diabetes
A.M. Nucci, D.J. Becker, S.M. Virtanen, D. Cuthbertson, B. Softness, C. Huot,
R. Wasikowa, H.M. Dosch, H.K. Akerblom0, M. Knip, The Trigr Study Group
O/3/WED/04
ZnT8 Autoantibody Specificities At, and 3-5 Years After Clinical Onset, Associates
with the Age at Diagnosis and the SLC30A8 Gene Polymorphism in Danish
Children with Type 1 Diabetes.
J.S. Sørensen, F. Vaziri-Sani, F. Pociot, K. Kristensen, C. Brorsson, L. Lyngsoe,
B. Dolmer, N.H. Birkebaek
O/3/WED/05
Early Life Determinants of Paediatric Onset Type 1 Diabetes Mellitus with a Focus
on Low Sun Exposure.
A.-L. Ponsonby, A. Pezic, F. Cameron, C. Rodda, J. Ellis, J. Halliday, J. Carlin, T. Dwyer,
O/3/WED/06
Association of the WFS1 Gene with Disease Progression in Children with New
Onset T1D. Results from the Hvidoere Study Group on Childhood Diabetes.
L.B. Nielsen, M.L.M. Andersen, J. Svensson, S. Pörksen, P. Hougaard, P. Swift, H. Hoey,
H.B. Mortensen, L. Hansen, The Hvidoere Study Group On Childhood Diabetes
O/3/WED/07
The Incidence of Childhood Onset Type 1 Diabetes in Norway is Steadly
Increasing for Both Sexes
T. Skrivarhaug, L.C. Stene, H. Strøm, A.K. Drivvoll, P.R. Njølstad, G. Joner,
The Norwegian Childhood Diabetes Study Group
O/3/WED/08
Thirty Years of Prospective Nationwide Incidence of Childhood Type1 Diabetes the Accelerating Increase by Time Tends to Level off in Sweden
Y.T. Berhan, I. Waernbaum, T. Lind, A. Mollsten, G.G. Dahlquist, Swedish Childhood
Diabetes Study Group
18.30 - 19.00
Opening Ceremony
Libertador B/C
Chairs: Olga Ramos (Argentina), Thomas Danne (Germany)
16
Scientific Program
Thursday, October 28
Breakfast Symposium: Roche
07.30 - 08.30
Technological Advancement in Diabetes Care for Children and Adolescents:
Libertador C
Progress or Flash in the Pan?
Chair: Lynda K. Fisher (United States)
Results of the Implementation of Insulin Pump Treatment at a National Level.
Knut Dahl-Jorgensen (Norway)
How Do We Solve the Problem of Maria: The Headache of Adolescence
William H. Lamb (United Kingdom)
Para Lograr la Adhesión al Tratamiento, ¿Utilizamos la Educación Diabetológica
Como Recurso Terapéutico?“ („Shall We Use Diabetes Education as a Therapeutic
Resource to Achieve Treatment Adherence?“
Marta Molinero de Rópolo (Argentina)
During this session, therapeutic approaches towards improving the care for children and
adolescents with diabetes will be reviewed, and the contribution of technological advances
discussed. One symposium topic are the results of the implementation of insulin pump therapy at
a national level. Furthermore, strategies addressing the challenges of diabetes care in adolescents
will be shared. Finally, the role of diabetes education in achieving treatment adherence in children
with diabetes is going to be evaluated.
Breakfast Workshop I: Medtronic
CareLink
TM
Workshop op
07.30 - 08.30
Martin Fiero 1
Solving the Puzzle of Diabetes with CareLinkTM Therapy Management Software
Speaker: Henk Veeze (The Netherlands)
Pre-registration required, available on the conference website.
Breakfast Symposium: Eli Lilly and Company
Advances in the Understanding and Treatment of Type 1 Diabetes
08.00 - 09.00
Libertador A
Chairs: Olga Ramos (Argentina)
Welcome and Introduction
Advances in the Understanding and Treatment of Type 1 Diabetes
Ragnar Hanås (Sweden)
Question & Answer Session
Closing Remarks
17
Scientific Program
09.00 - 10.30
Plenary Session III:
Libertador B/C
Emerging Trends in Obesity Research
Chairs: Sylvia Asenjo (Chile), Warren Lee (Singapore)
Lestradet Award Lecture
Insights Into the Pathogenesis of Childhood Obesity
Ram Weiss (Israel)
Hypothalamic Obesity: Pathogenesis and Natural History
Jill Hamilton (Canada)
11.00 - 12.30
Symposium I:
Libertador A
Bad Visions: Substance Abuse in Youngsters with Diabetes
Chairs: Marie Hallmann (Sweden), Neil White (United States)
Smoking and Metabolic Control
Sabine Hofer (Austria)
Substance Abuse and Metabolic Control
Paul Lee (Australia)
Adressing Risk Behavior in Adolescents with Diabetes
Kristina Berg-Kelly (Sweden)
11.00 - 12.30
Symposium II:
Libertador C
The Loop Club: Is Closing It Near Reality?
Chairs: Moshe Phillip (Israel), Przemka Jarosz-Chobot (Poland)
Pumps and Sensors from the Onset of Diabetes?
Olga Kordonouri (Germany)
Meal Detection for Closing the Loop
Eyal Dassau (United States)
Which Roadblocks Need to be Removerd on the Way to the Closed Loop?
Roman Hovorka (United Kingdom)
18
Scientific Program
Lunch Workshop I: Medtronic
iPro
TM
2 Professional CGM : Integrating the Latest Retrospective CGM Device into
12.30 – 13.30
Ombú 1 + 2
Clinical Practice
Speaker: Orit Pinhas-Hamiel (Israel)
Lunch Workshop: Roche
The Accu-Chek Combo insulin pump system – practical tools to empower children
on CSII and their parents.
Symposium III:
The View From the Beta-Cell: A Cure in Sight?
12.30 – 13.30
Martín Fiero 2
13.30 - 15.00
Libertador A
Chairs: Leon Litwak (Argentina), Denis Daneman (Canada)
Beta-Cell Regeneration - Is it Possible?
Catarina Limbert (Portugal)
Combination Therapies to Preserve Beta-Cell Function
Matthiasvon Herrath (United States)
Stem Cell Therapy for Type 1 Diabetes
J.C. Voltarelli (Brazil)
Symposium IV
13.30 - 15.00
Looking Healthy: Exercise and Diabetes
Libertador B
Chairs: Gloria Montagna (Argentina), Lori Laffel (United States)
Exercise and Metabolic Control
Jan Aman (Sweden)
Algorithms for Dose Adjustment During Exercise
Michaek Riddell (Canada)
Exercise and Continuous Glucose Monitoring
Tadej Battelino (Slovenia)
19
Scientific Program
Friday, October 29
07.30 - 08.30
Breakfast Symposium: Novo Nordisk
Libertador A
Challenges Across the Biological and Psycho-social Spectrum: Optimizing
Safety & Quality of Life within Pediatric Diabetes Care
Chair: Liliana Trifone (Argentina)
Welcome and Introduction
Liliana Trifone (Argentina)
Mitogenicity: Taking Safety Seriously
David Russell-Jones (United Kingdom)
Individualized Care: The Challenges of Treating the Pediatric Population
Kenneth Copeland (United States)
The Psycho-social Challenges in the Paediatric Population: Barriers to Glycaemic Control
Carine de Beaufort (Luxembourg)
Panel Discussion
Closing Remarks
Liliana Trifone (Argentina)
07.30 - 08.30
Breakfast Workshop II: Medtronic
Martin Fiero 1
CareLinkTM Workshop op
Solving the Puzzle of Diabetes with CareLinkTM Therapy Management Software
Speaker: Henk Veeze (The Netherlands)
09.00 - 10.30
Plenary Session IV:
Libertador B/C
Real Numbers: Data Bases for Pediatric Diabetes Research
Chairs: Kenneth J. Robertson (United Kingdom), Henk Veeze (The Netherlands)
Young Investigator Award Lecture
Outcomes research in the US Pediatric Diabetes Consortium
The Canadian Prospective Non-Type 1 Diabetes Study
Jill Hamilton (Canada)
SWEET - An Electronic Health Record for Pediatric Diabetes Reference Centers
Thomas Danne (Germany)
Outcomes Research in the US Pediatric Diabetes Consortium
William Tamborlane (United States)
20
Scientific Program
Friday, October 29
Oral Session IV
Psychosocial Issues & Education in Diabetic Youth
11.00 - 12.30
Libertador A
Chairs: Thais Della Manna (Brazil), Hans-Jacob Bangstad (Norway)
O/4/FRI/01
Mental State at Diagnosis Predicts Intellectual Outcome in Children 6 Months
After Diagnosis of Type 1 Diabetes
C. Nadebaum, S.E. Scratch, E.A. Northam, F.J. Cameron, Diabetic Ketoacidosis And
Brain Injury Study Group
O/4/FRI/02
Intervenient Variables in the Acceptance of a Diabetes Educational Program in Children
and Its Impact on the Pillars of the Treatment. Repercussion over Metabolic Control.
A.M. Figueroa Sobrero, F. Walz, N. Orzuza, E. Baraballe, A. Perez De Laporta,
S. Panzitta, J.C. Cernuda
O/4/FRI/03
Lower Achieved A1C Among Adolescents with Lower Perceived A1C Goal
R.P. Wadwa, M.D. Anger, F.K. Bishop, E. Cruz, G.J. Klingensmith, D.M. Maahs
O/4/FRI/04
Parental Health Literacy and Glycemic Control in Young Children with Type 1
Diabetes
E.R. Pulgaron, A.M. Patino-Fernandez, D. Wile, J. Sanchez, L. Sanders, A. Delamater
O/4/FRI/06
HbA1c Tracking in Patients with Type 1 Diabetes - from Diabetes Onset in
Childhood, During Puberty and Adolescence Into Adulthood.
S.E. Hofer, A. Naeke, A. Herbst, J. Rosenbauer, D. Dunstheimer, E. Lilienthal, W. Marg,
R.W. Holl, Dpv Science Study Group
O/4/FRI/07
Digital Sugarsquare Leads to Better Appreciation of Care and Better
Communication Between Caregiver and Adolescent with Diabetes
E. Boogerd, C. Verhaak, C. Noordam
O/4/FRI/08
Sibling’s Knowledge of Diabetes and Treatment
E. Goethals, D. Verbrugghe, T. Havermans, K. Casteels
21
Scientific Program
Friday, October 29
11.00 - 12.30
Oral Session V
Libertador B
Unraveling the Genetic Basis of Diabetes in Children
Chairs: Jeremy Allgrove (United Kingdom), Ľubomír Barák (Slovakia)
O/5/FRI/01
Monogenic Diabetes in Infants: Time to Extend Genetic Testing Beyond the First 6
Months of Life?
O. Rubio-Cabezas, S.E. Flanagan, A. Damhuis, E.L. Edghill, A.T. Hattersley, S. Ellard
O/5/FRI/02
Using Clinical Criteria to Improve the Use of Genetic Testing in Diabetes
T. Mcdonald, B.M. Shields, S. Ellard, A.T. Hattersley
O/5/FRI/03
Sex Differences in the Development of Diabetes In mice with Deleted Wolframin
(Wfs1) Gene - an Animal Model for Wolfram Syndrome
K. Noormets, S. Koks, M. Muldmaa, L. Mauring, E. Vasar, V. Tillmann
O/5/FRI/04
Two Ancestral Mutations in a Large Number of Czech Families with Glucokinase
Diabetes
P. Dusatkova, S. Pruhova, J. Lebl, O. Cinek
O/5/FRI/05
Frequency of Polymorphisms of KCNJ11, INS VNTR and NR3C1 Genes in Children
with Small Gestational Age in Polish Population
M. Szalapska, M. Borowiec, K. Antosik, W. Mlynarski, R. Stawerska, M. Hilczer,
A. Lewinski
O/5/FRI/06
The First Nationwide Multicenter Study on the HLA-DRB1, DQB1, DPB1 Genotypes
in Japanese Children with Type 1 Diabetes and Their Families
S. Sugihara, S. Amemiya, T. Ogata, T. Kawamura, T. Urakami, N. Kikuchi, The Japanese Study Group Of Insulin Therapy For Childhood And Adolescent Diabetes (Jsgit)
O/5/FRI/07
Specific Clinical Pattern for Glucokinase Gene Mutations in MODY Families
M. Borowiec, K. Antosik, W. Fendler, G. Deja, P. Jarosz-Chobot, M. Misliwiec,
A. Zmyslowska, A. Szadkowska, M. Malecki, W. Mlynarski
22
Scientific Program
Friday, October 29
O/5/FRI/08
A Novel Wolcott-rallison Syndrome Mutation in Two Members of an Irish
Consanguinous Family
M. White, C. `Costigan, D. Cody
Oral Session VI
Update in Clinical Care of Pediatric Diabetes
11.00 - 12.30
Libertador C
Chairs: Maria Cristina Belzarena (Uruguay), Peter Adolfsson (Sweden)
O/6/FRI/01
Subcutaneous Use of Rapid Insulin Analog: An Alternative Treatment for Patients
with Mild to Moderate Diabetic Ketoacidosis
I. El Ebrashy, M.H.M.F. El Hefnawy, A. Basyouni, H. Mahfouz
O/6/FRI/02
Glycemic Variability in Pediatric Patients with Diabetes Mellitus Type 1;
A Comparison Between Treatments and Its Relation with Oxidative Stress.
M. Angulo, M. Torres, R. Cardona, C. Valls, A. Gomez
O/6/FRI/03
Improved Metabolic Control and Treatment Satisfaction in Patients Using an
Integrated Infusion Pump System for Continuous Subcutaneous Insulin Infusion (CSII)
G.E.M. Storms, R.P.L.M. Hoogma, D. Kerr, A. Buhr, B. Petersen, On Behalf Of The Study
Investigators.
O/6/FRI/04
Glucose Excursions in Children and Adolescents in the STAR 3 Study: A 1-Year
Randomized Controlled Trial Comparing Sensor-Augmented Pump Therapy to
Multiple Daily Injections
R.H. Slover, W.V. Tamborlane, T. Battelino, A. Criego, M. Daniels, C. Foster,
R.C. Mcevoy, C. Orlowski, S. Weinzimer, N.H. White, S. Willi0, M.A. Wood
O/6/FRI/05
Doubled rate of Hypoglycemic Events Detected by CGM Compared to Frequent
SMBG in Children < 7 Years of Age
F. Sundberg, G. Forsander
O/6/FRI/06
Diabetic Ketoacidosis at Onset of T1DM Associates to Future HbA1c Levels
J. Johannesen, L. Lyngsøe, H. Rida, M.L. Andersen, M.H. Lauridsen, B. Hertz,
N.H. Birkebæk, B. Olsen, J. Svensson
23
Scientific Program
Friday, October 29
O/6/FRI/07
Analyses of the Rate of Decline in Stimulated C-peptide 12 Months After
Diagnosis in Children with Newly Diagnosed Type 1 Diabetes. Results from the
Hvidoere Study Group on Childhood Diabetes
M.L.M. Andersen, S. Pörksen, L.B. Nielsen, J. Svensson, J. Johannesen, P. Hougaard,
J.V. Jørgensen, J. Thomsen, N.T. Hertel, J.S. Petersen, A.E. Karlsen, L. Hansen,
H.B. Mortensen
O/6/FRI/08
Long-Term Follow-Up in Children and Adolescents with Type 1 Diabetes and
Abnormal Urinary Albumin Excretion (UAE)
S. Salardi, S. Zucchini, C. Balsamo, G. Maltoni, M. Scipione, A. Rollo, S. Gualandi,
A. Cicognani
12.30 – 13.30
Lunch Workshop I: Medtronic
Obmú 1 + 2
iProTM 2 Professional CGM : Integrating the Latest Retrospective CGM Device into
Clinical Practice
Speaker: Orit Pinhas-Hamiel (Israel)
13.30 - 14.30
Poster Session II
Retiro
Please see the poster section for details.
14.30 - 16.00
Symposium VII:
Libertador A
New Approaches to Diabetes Psychology for the Real World
Chairs: Lucila Agnese (Argentina), Andrew Cotteril (Australia)
Involving a Psychologist From the Onset
Gun Forsander (Sweden)
Youth-parent Interaction as Intervention Target
Tim Wysocki (United States)
Discussing Health-related Quality of Life with Adolescents
Maartje de Wit (The Netherlands)
24
Scientific Program
Friday, October 29
Symposium VIII:
14.30 - 16.00
Early Complications: A Nutritional View
Libertador C
Chairs: Maria Emilia Mazzei (Argentina), Sheridan Waldron (United Kingdom)
heridan Waldron (UK)
Nutrition and Microalbuminuria
Carmel Smart (Australia)
Nutrition and Hypertension
Ingrid Libman (United States)
Nutrition and Dislipidemia
Margaret McGill (Australia)
ISPAD Annual Assembly
16.30 - 18.00
Chair: Thomas Danne (Germany), Kenneth J. Robertson (United Kingdom),
Libertador C
Ragnar Hanås (Sweden)
25
Scientific Program
Saturday, October 30
09.00 - 10.30
Libertador B/C
Plenary Session V:
On the Lookout for the Right Target: The Current Situation of Diabetes Prevention
Chair: Mabel Ferraro (Argentina), Dorothy Becker (United States)
Should we Target Viruses to Prevent Diabetes?
Maria Craig (Australia)
Immunosuppression Studies Aimed at Interdicting and Preventing Type 1
Diabetes (T1DM)
Desmond Schatz (United States)
C-Peptide as Surrogate Therapeutic Marker for a Successful Outcome
Paolo Pozzilli (Italy)
11.00 - 12.30
Symposium V:
Libertador A
Ethical Viewpoint: What are the Limits of Pharmacological Intervention in the
Paediatric Patients with DM?
Chair: Manuel Vera Gonzalez (Cuba), Joseph Wolfsdorf (United States)
Interventions in the Context of Difficult Psychosocial Situations
Kuben Pillay (South Africa)
Global Inequalities and Pediatric Research
Aman Pulungan (Indonesia)
Parents View vs. Child Autonomy
Johnny Ludvigsson (Sweden)
The Approach of Regulatory Bodies such as EMEA
Carine de Beaufort(Luxembourg)
Roundtable Discussion
26
Scientific Program
Saturday, October 30
Symposium VI:
Looking at the Genes - New Insights
11.00 - 12.30
Libertador C
Chair: Gustavo Frechtel (Argentina), Mark Sperling (United States)
Neonatal Diabetes and Pancreatic Hypoplasia
Julian Hamilton-Shield (United Kingdom)
How to Approach Monogenic Diabetes of Unknown Etiology
Sian Ellard ( United Kingdom)
Monogenic Diabetes and Positive Antibodies: Double Diabetes?
Wojchiech Mlynarski (Poland)
Closing Ceremony
12.30 - 13.00
Chairs: Olga Ramos (Argentina), Thomas Danne (Germany),
Libertador B
Lynda Fisher (United States)
27
Posters
P/001/WED
–
P/008/WED
P/019/WED
–
P/027/WED
P/055/WED
–
P/063/WED
P/074/WED
–
P/084/WED
P/096/WED
–
P/106/WED
P/118/WED
–
P/127/WED
P/136/WED
–
P/143/WED
P/039/WED
–
P/045/WED
P/009/FRI
–
P/018/FRI
P/028/FRI
–
P/038/FRI
P/046/FRI
–
P/054/FRI
P/064/FRI
–
P/073/FRI
P/085/FRI
–
P/095/FRI
P/107/FRI
–
P/117/FRI
P/154/WED
–
P/160/WED
P/170/WED
–
P/178/WED
P/144/FRI
–
P/153/FRI
P/128/FRI
–
P/135/FRI
P/179/FRI
–
P/186/FRI
P/187/WED
–
P/196/WED
P/197/FRI
–
P/205/FRI
P/161/FRI
–
P/169/FRI
Libertador
Room
Retiro
28
Posters
P/001/WED – P/008/WED
Poster Session I
Chronic Complications
Wednesday, October 28th, 2010
P/009/FRI – P/018/FRI
Poster Session XII
Diabetic Ketoacidosis
Friday, October 29th, 2010
P/019/WED – P/027/WED
Poster Session II
Macroangiopathy and Type 2 Diabetes
P/028/FRI – P/038/FRI
Poster Session XII
Cohorts and Countries
P/039/WED – P/045/WED
Poster Session III
Endocrinology and Diabetes
P/046/FRI – P/054/FRI
Poster Session XIV
Obesity I
P/055/WED – P/063/WED
Poster Session IV
Obesity II
P/064/FRI – P/073/FRI
Poster Session IV
Education I
P/074/WED – P/084/WED
Poster Session V
Education II
P/085/FRI – P/095/FRI
Poster Session XVI
Psychosocial I
P/096/WED – P/106/WED
Poster Session VI
Psychosocial II
P/107/FRI – P/117/FRI
Poster Session XVII
Psychosocial III
P/118/WED – P/127/WED
Poster Session VII
Onset of diabetes
P/128/FRI – P/135/FRI
Poster Session XVIII
New Treatment Options
P/136/WED– P/143/WED
Poster Session VIII
Case Presentations
P/144/FRI – P/153/FRI
Poster Session IXX
Diabetes Genetics, Immunology
P/154/WED – P/160/WED
Poster Session IX
Diabetes from devloping countries
P/161/FRI – P/169/FRI
Poster Session XX
Monogenic Diabetes
P/170/WED – P/178/WED
Poster Session X
Pumps and Sensors I
P/179/FRI – P/186/FRI
Poster Session XXI
Pumps and Sensors II
P/187/WED– P/196/WED
Poster Session XXI
Type 2 Diabetes in Children
P/197/FRI – P/205/FRI
Poster Session XXII
Varia
29
Posters
■ Poster Session I
Chronic Complications
Chairs: David Maahs (United States), Peter Swift (United
Kingdom)
P/011/FRI
Primary Prevention of DKA: A Campaign to Raise Awareness of Diabetes Symptoms in the Community
D.H. Jelley, C.G. Marra, J. Paul
P/001/WED
Study of Coronary Artery Calcification Risk in Egyptian
Adolescents with Type 1 Diabetes
M.A.K. Salem, E.M. Sherif, A.A.M. Adly, K. Essamet
P/012/FRI
Diabetic Ketoacidosis Management Safe and Simple.
W.J. Van Ijperen Sr, E. Peeters, W.J. Van Ijperen
P/002/WED
Visual Evoked Potentials in Children and Adolescents with
Type 1 Diabetes Mellitus
M.H. El Samahy, R.M. Matter, A.M. Nassef, A.F. Osman
P/003/WED
Predictors of Cognitive Impairment in Children and
Adolescents with Type 1 Diabetes Mellitus
M.H. El Samahy, S.M. Farid, H.M. Azzam, S.M. Sayed,
M.A.K. Salem
P/005/WED
Possibly Promising Methods in Detecting Early Signs of
Peripheral Diabetic Neuropathy in Young Patients with Type
1 Diabetes Mellitus.
J.C. Van Der Heyden, P. Van Der Meer, E. Birnie, G.H. Visser,
I.F.M. Coo, H.J. Veeze, H.J. Aanstoot, J.H. Blok
P/006/WED
Cystopathy in Children and Adolescents with Type 1
Diabetes Mellitus
S.A. Elhabashy, Salem A K Mona, Shaker S Hassan, Hetta M A
Hosama , Toaima N Dalia, Elkafy H A Jonair
P/008/WED
Pilot Study Into the Efficacy Of a Novel, Non-invasive
approach to Studying the Affects of Acute Hyperglycemia on
Cognitive and Psychosocial Variables in Adolescents
V. Mc Darby, C. Costigan, S. Carroll
■ Poster Session XII
Chairs: Jannet Svensson (Denmark), Blanca Ozuna (Argentina)
P/009/FRI
Epidemiological Pattern of Diabetic Ketoacidosis, in National
Institute of Diabetes and Endocrinology (NIDE), Cairo, Egypt
A. Bassyouni, I. El Ebrashy, M.H. El Hefnawy, M.H. Mahfouz
P/010/FRI
Increasing Prevalence of Ketoacidosis in Children Diagnosed
with Diabetes, Colorado, 1978-2009
A. Rewers, G. Klingensmith, M. Rewers
30
P/013/FRI
Evaluation of Capillary ß-hydroxybutyrate Measurement in
M.H. El Hefnawy, A.A.M. Bassyouni, I. Emara
P/014/FRI
Multicentric Study of Diabetic Ketoacidosis in Pediatric
Units in Argentina
M. Ferraro, B. Ozuna, C. Mazza, O. Ramos, P. Evangelista, C. Mannucci, M. Gandolfo, Y. Camiser, R. Varela, A. Figueroa Sobrero,
S. Gonzalez, F. Palacios, S.M. Lopez, M. Ropolo0, L. Caratcoche, L. Trifone, M.L. Eandi, G. De Freijo, D. Fernandez, M.E. Pianesi, E. Scaiola
P/015/FRI
Diabetic Ketoacidosis in North India
S. Kalra, B. Kalra, A. Sharma
P/016/FRI
Frequency and Clinical Characteristics of Ketoacidosis at
Onset of Childhood Type 1 Diabetes Mellitus M.D. Jesic, S. Sajic, V. Zdravkovic, V. Bojic, M. Nikolic, M.M. Jesic
P/017/FRI
The Impact of Diabetic Ketoacidosis and Age on Behaviour
six months Post-diagnosis in Children with Type 1 Diabetes
S.E. Scratch, C. Nadebaum, E.A. Northam, F.J. Cameron,
Diabetic Ketoacidosis And Brain Injury Study Group
P/018/FRI
Outpatient blood ketone monitoring: A Scottish perspective
C.J. Stutchfield, K. Noyes, L. Bath
■ Poster Session II
Macroangiopathy and Type 2 Diabetes
Chairs: Lynne Levitzky (United States), Jean-Jacques
Robert (France)
P/019/WED
Carotid Artery Intima-media Thickening and Biochemical
Markers of Cardiovascular Risk in Obesity and Type 1
Diabetes in Children and Youngs.
M.E. Andres, O. Ramos, A. Franchello, P. Marino, S. Barbeito,
I. Strasnoy, C. Mannucci, M. Ferraro. Nutrition And Diabetes
Unit. Pedro De Elizalde´s Children Hospital
Posters
P/020/WED
Macroangiopathy Risk Factors in Well-controlled Adolescents with Type 1 Diabetes – the Impact of Sex..
L.J. Machnica, G. Deja, J. Polanska, P. Jarosz-Chobot
■ Poster Session XIII
Cohorts and Countries
Chairs: Carlo Acerini (United Kingdom), Francois Bonnici
(South Africa)
P/021/WED
Is Exercise a Therapeutic Tool for Improvement of Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes
Mellitus? A Randomised Controlled Trial
M. Salem, M. Abo-Elasrar, N. Elbarbary, R. El-Hilaly, Y. Refaat
P/028/FRI
Comparative Evaluation of Glycemic Balance in Children and
Adolescents with Diabetes Mellitus Type-1 After the
Implementation of Self-monitoring Tests Distributed
Through the National Program in Romania
R. Giurescu, I. Micle, M. Marazan, E. Pop, M. Costescu,
N. Kundnani
P/022/WED
Obesity and Body fat in Type 1 Diabetic Children and
Adolescents
A. Szadkowska, A. Gadzicka, L. Ostrowska-Nawarycz,
T. Nawarycz, B. Mianowska, K. Włodarczyk, I. Pietrzak
P/023/WED
More Atherogenic Cardiovascular Disease Risk Profile in
Females than Males Who Exceed A1c Goals
R.P. Wadwa, F.K. Bishop, J.K. Snell-Bergeon, G.L. Kinney,
D.M. Maahs
P/024/WED
Glycated Haemoglobin A1c (HbA1c) in Children with Long
Type 1 Diabetes (T1DM) Duration
A. Gawron, J. Polanska, M. Chumiecki, B. Echolc, A. Chobot,
P. Jarosz-Chobot
P/025/WED
Pediatric Patients with Clinical Type-2-Diabetes - What
Does the Presence of B-cell-antibodies mean? Data from the
Austrian/German DPV Register
E. Schober, T. Meissner, S. Wiegand, A. Thon, P. Beyer,
T. Reinehr, W. Awa, A. Dost, J. Rohayem, R. Holl
P/026/WED
Type 2 Diabetes in Peruvian Children. A case Series
M.E. Pinto, H.M. Manrique
P/027/WED
Difference in Glycosylated Albumin (GA)/HbA1c ratio as a
Glycemic Index Between Children with Type 1 and Type 2
Diabetes
K. Komiya, T. Urakami, A. Yoshida, J. Suzuki, M. Ishige, H. Saito,
S. Takahashi, H. Mugishima
P/029/FRI
Initiative for Quality improvement and Epidemiology in
Children and Adolescents with type 1 Diabetes in Belgium
(IQECAD): Results of First Data Collection
K. Doggen, N. Debacker, V. Van Casteren, Iqecad Scientific
Steering Committee
P/030/FRI
Implementation of Australian Pediatric Endocrine Group (APEG)
Clinical Management Guidelines: Are We Doing Enough?
K.L. Hatherly, J. Overland, L. Smith, C. Johnston, L. Brown-Singh,
D. Waller, S. Taylor
P/031/FRI
Structure of Pediatric Diabetes Care in Germany 1998 –
2008: Increased Centralization and Qualification of
Multidisciplinary Teams
K. Lange, A. Gocz, T. Danne, A. Neu, On Behalf Of The GermanWorking Group For Paediatric Diabetes (Agpd)
P/032/FRI
Chronic Complications of Type 1 Diabetes Mellitus (DM) in
Pediatric Based on the UCDR in Ukraine
Y. Globa, N. Zelinska
P/033/FRI
Follow-up Survey of All Participants at the First and Second
Juvenile Diabetes Summer Camp in Japan in 1963 and 1964
Y. Uchigata, T. Otani, T. Kasahara, H. Takaike, H. Maruyama,
Y. Iwamoto
P/034/FRI
An Estimation of Metabolic Compensation Level and
Prevalence of Diabetes Complications in Russian Childrens
and Adolescents Population.
E.A. Andrianova, T.Y. Shiryaeva, I.I. Alexandrova, T.L. Kuraeva,
Y.I. Suntzov
P/035/FRI
Metabolic Control in Danish Adolescents. Is Transition the
Problem?
J. Thomsen, P.-E. Kofoed, C. Thomsen, J. Kolding Kristensen
31
Posters
P/036/FRI
Efficacy and Feasibility of Multiple Insulin Injections
Regimen in a Cohort of Tanzanian Children with Type 1
Diabetes Mellitus (T1DM)
E.S. Majaliwa, V. Iotova, K. Ramaiya, K. Muze, Paediatric
Diabetes Clinic, Muhimbili National Hospital
P/037/FRI
Pandemic Influenza A H1N1 in Italian Children and
I. Rabbone, A. Scaramuzza, D. Iafusco, R. Bonfanti, F. Lombardo,
V. Cherubini, S. Toni, G.V. Zuccotti, G. Tuli, F. Cerutti
P/038/FRI
Documenting and Improving the Structure, Process and
Outcome of Pediatric Diabetes Care: 15 Year Experience from
the Austrian/German DPV initiative.
B. Rami, S. Bechtold-Dal Pozza, O. Kordonouri, B. Schenk,
N. Treptau, A. Hungerle, R.W. Holl
P/044/WED
Hormonal and Metabolic Response During Physical Exercise
of Different Intensity in Healthy Controls and Adolescents
with Type 1 Diabetes
P. Adolfsson, B. Lindblad
P/045/WED
Thyroid Function and Anti-thyroid Antibodies in Portuguese
Children and Adolescents Patients with Type 1 Diabetes
Mellitus: Influence of Age, Sex and Duration of the Diabetes
C.S.F. Costa, C. Castro-Correia, I. Carvalho, M. Fontoura,
■ Poster Session XIV
Obesity I
Chairs: Stephen Duck (United States), Irina Osokina (Russian
Federation)
■ Poster Session III
Endocrinology and Diabetes
Chairs: Axel Dost (Germany), Patricia Gallego (Australia)
P/046/FRI
Insulin Resistance is Associated with 3-fold Increased Risk
for Prothrombotic State in Obese Youngsters
A. Galli-Tsinopoulou, I. Kyrgios, I. Maggana, E.Z. Giannopoulou,
E.P. Kotanidou, C. Stylianou, E. Papadakis, I. Korantzis,
G. Varlamis
P/039/WED
Serum Osteocalcin, Zinc Nutritive Status and Bone Turnover
in Children and Adolescents with Type1 Diabetes Mellitus
M. Aboelasrar, S. Farid, M. El Maraghy, A. Mohamedeen
P/047/FRI
Risk of Impaired Glucose Tolerance in Obese Children and
Adolescents
M. Kocova, E. Sukarova-Angelovska, S. Spasevska
P/040/WED
Bone Maturation in 1788 Children and Adolescents with
Diabetes Mellitus Type 1
A. Dost, T. Rohrer, J. Fussenegger, C. Vogel, B. Schenk,
M. Wabitsch, B. Karges, C. Vilser, R.W. Holl, Initiative Dpv
Science And German Competence Network Diabetes
P/048/FRI
Hepatic and Pancreatic Fat and Associated Metabolic
Parameters in Overweight Youth
C. Syme, G. Wells, G. Detzler, H. Cheng, B. Mccrindle, J. Hamilton
P/041/WED
Ovulation Rate in Adolescents with Type 1 Diabetes Mellitus
and its Association with Metabolic Control
F.C. Eyzaguirre, R. Román, G. Iñíguez, P. López, F. Pérez-Bravo,
I.M. Torrealba, F. Cassorla, E. Codner
P/042/WED
Plasma Ghrelin Level in Children and Adolescents with Type
1 Diabetes Mellitus
R.M. Matter, S.M. Farid, M.M. Abdel Aziz, S.A. Hamza
P/043/WED
Must We Look for Cushing Disease (CD) in Obese
Glucose-Intolerant Children and Adolescents?
L.L. Levitsky, E. Savgan-Gurol, M. Misra
32
P/049/FRI
YKL-40 is a Marker of Obesity and Insulin Resistance in
Obese Prepubertal Children
A. Galli-Tsinopoulou, I. Kyrgios, E. Papakonstantinou,
A.-B. Haidich, C. Stylianou
P/050/FRI
Level of Physical Activity Among Children of 6-18 Years of
Age - Contributing Factors to the Level of Physical Activity
and Associated Outcome in Terms of Glycemic Control and
Body Mass Index.
P. Adolfsson, B. Lindblad
P/051/FRI
Type 2 Diabetes Risk Reduction for Obese Hispanic Children:
A Pilot Study
A.M. Delamater, E. Pulgaron, A.M. Patino-Fernandez,
F. Jacquez, M. Villa, J. Hernandez, J. Sanchez
Posters
P/052/FRI
Relationship between Body Mass Index and Blood Pressure
Among Nigerian Children Aged 6-18Years
J. Elusiyan, A.S. Adegoke
P/060/WED
Prevalence of and Associated Factors of Childhood Obesity
Among High School Children of Pakistan
J. Ahmed
P/053/FRI
Association of Lower Serum Magnesium with Overweight
and Insulin Resistance in Children and Adolescents
V. Jain, B. Jose, N.K. Vikram
P/061/WED
The Usefulness of Using OGTT in the Follow-up of SGA
Children Treated with GH on the Various Clinical Conditions
in Japanese Children
K. Kobayashi, S. Amemiya, K. Kobayashi, J. Akatsuka, T. Saito,
M. Hoshino, K. Kobayashi, A. Ohtake, K. Ohyama, N. Matsuura
P/054/FRI
Eating Behaviour: Do Adolescents with Diabetes Eat
Differently Compared to Healthy Adolescent?
C. De Beaufort, M.T. Damsgaard, N. Ahluwalia, M. Rasmussen,
B. Holstein, K. Lange, C. Skinner, P. Swift, P. Due, H. Mortensen,
Hbsc Group And Hvidoere Study Group
P/063/WED
Frequency of Occurrence of Obesity Among Children of
Megalopolis Samara
A. Kulyashova, E. Michailova
■ Poster Session IV
Obesity II
Chairs: Shin Amemiya (Japan), Violeta Iotova (Bulgaria)
■ Poster Session IV
Education
Chairs: Marcia Frank (Canada), DamlaGökşen (Turkey)
P/055/WED
Body Fat Distribution in Overweight and Obese Children:
What Predicts Best Hormonal, Metabolic and Inflammatory
Profiles in Children?
C. De Beaufort, H. Samouda, U. Schierloh, J. Jacob, V. Bocquet,
F. Dadoun, And Ospel
P/064/FRI
‘Carol’s Got Diabetes’: Another Step Towards Achieving
Regular Schooling for Children with Diabetes.
M.C. Marin, V. Salaverría, I. Lorente, A. Lorenzo
P/056/WED
Genetic Association of FTO, ENPP1 and APMl Gene
Polymorphisms with Obesity and Related Parameters in
Chinese Children and Adolescent
Z. Zheng, F. Luo, L. Cao, Y. Yang, S. Shen
P/057/WED
Stability of Metabolic Syndrome in Chilean School Children:
A Cohort Study
A.I. Godoy, R.D. Bancalari, C. Fardella, C. Campino, M. Aglony,
A. Martinez, P. Arnaiz, H. García
P/058/WED
How Body Mass Index and Body fat Mass Correlate with
Physical Activity in Urban Belarusian School Children
Y. Vainilovich, L. Danilova, M. Lushchyk, Z. Sretenskaya
P/059/WED
Higher Metabolic Risk for Overweight/Obese Children Aborting Therapy to Loose Weight
U. Schierloh, H. Samouda, C. De Beaufort, J. Jacobs, J.F. Vervier,
V. Bocquet, G. Gilson, Ospel Study Group
P/065/FRI
DAWN Youth Survey: Role of Schools for Youth with Diabetes
in India
D.G. Dalal, S. Kalra, A.K. Jhingan, S.K. Singh, V. Garg, N. Agrawal
P/066/FRI
Carol’s Corner: A Worldwide Site on Diabetes at School.
M.C. Marin, V. Salaverría
P/067/FRI
Development of a Web-based Support Intervention for
Parents of Teenagers with Type 1 Diabetes. What is Needed?
A.M. Goutbeek, M. De Wit, F.J. Snoek
P/068/FRI
A Visual Educational Tool for People with Literacy and
Numeracy Difficulties Caring for Children with Type 1
Diabetes
L. Andrews, D. Cody
P/069/FRI
Education in Insulin Dose Adjustment/Carbohydrate
Counting Techniques in Children with Type 1 Diabetes: A
Pilot UK Survey
S. Slegtenhorst, S. Waldron, C.L. Acerini
33
Posters
P/070/FRI
Helping Children with Type 1 Diabetes at Kindergarden and
Schools:a French Regional Training Program for Health Care
Professionals (HCP)
A.M. Bertrand, L. Vincent, B. Mignot, C. Ballot, M. Vias,
M. Cahane, J.J. Robert
P/071/FRI
Evaluating the Effect of a Blended Learning Programme to
Improve Consultation Skills of Paediatric Diabetes Clinic
Staff (The DEPICTED Study).
J. Gregory, M. Robling, Depicted Study Group
P/072/FRI
Pilot Study of a Novel Structured Self Management Education Program For adolescents with Type 1 Diabetes.
B. Knight, H.D. Mcintyre, D. Harvey, V.L. Haggar, J. Hickleton,
S. Cole
P/073/FRI
Randomized Nutrition Education Intervention to Improve
Carbohydrate Counting Accuracy in Adolescents with Type 1
Diabetes
G. Spiegel, A. Bortsov, F.K. Bishop, G.J. Klingensmith, D. Owen,
E.J. Mayer-Davis, D.M. Maahs
■ Poster Session V
Education II
Chairs: Mona Salem (Egypt), Donald Anderson (Australia)
P/074/WED
Communication Skills of Healthcare Professionals in a Paediatric Diabetes Centre: Evaluation by Adolescent Patients
M. Dejonghe, W. Asscherickx, M. Van Houten, E. Goethals,
K. Casteels
P/075/WED
Diabetes Education in the Electronic Era: What Do Our
Patients and Families Want?
L.S. Youde
P/076/WED
Group Treatment for Teens with Type 1 Diabetes and
Caregivers
C.E. Munoz, L.K. Fisher, Y. Cespedes-Knadle, M. Carson
P/077/WED
Effect of Diabetes Self Management Education (DSME) on
Glycemic Control (HbA1c) in Children Suffering from Type 1
Diabetes Mellitus in a Local Hospital of Karachi, Pakistan.
A.A. Qayyum, J. Raza, S. Amir, M. Ibrahim, I. Atta
34
P/078/WED
Diabetes Education Program in Patients with Type 1
Diabetes Mellitus
M.H. Elsamahy, A.A. Abdelmaksoud, H.E. Azzam
P/079/WED
Quality Incentive Scheme: To Improve Glycaemic Control in
Children and Young People with Diabetes.
L. Terrett, Y. Oade, A. Oversby, R. Hagreen, H. Taylor,
N. Harrison, S. Schorah, M. Whiteley, L. Davies
P/080/WED
Exploring the Health-Related Quality of Life (HRQOL)
Experiences of Children and Adolescents with Cystic
Fibrosis Related Diabetes (CFRD)
S. Barrett, S. Carpenter, M.R. Frank, A. Newcombe, M. Solomon,
L. Taylor,
P/081/WED
Telephonic Patient Support: The Didi (Elder Sister) Project
N. Agrawal, S. Kalra, B. Kalra, S. Agrawal
P/082/WED
Coaching Improves the Metabolic Control in Teenagers With
Continuously High Glycosylated Hemoglobin - A Pilot Study.
P.-E. Kofoed, J. Thomsen, J. Ammentorp
P/083/WED
Education Program and Formal Training of Pediatric
Diabetic Patients Using the Bolus Calculator with Continuous Subcutaneous Insulin Infusion (Paradigm 522 or 722,
Medtronic Inc. and Accu-Check® Aviva Combo Meter, Roche).
L. Perrenoud, C. Bussien, M. Dirlewanger, G. Cimarelli,
M. Castellsague-Perolini, V. Schwitzgebel
P/084/WED
Diabetes Mellitus Type 1: Knowlegde about Insulin Injection
and Glucose Monitoring
E.B.C. Damiao, L.A. Kaneto, C.F. Antunes, M.S. Queiroz, M. Nery
■ Poster Session XVI
Psychosocial I
Chairs: Areti Philotheou (South Africa),
Marta Ropolo (Argentina)
P/085/FRI
Psychological State of the Families with Obese Children.
A. Solnceva, M. Vishnevskaya
P/086/FRI
Explaining Treatment Adherence by Risk and Health Behaviors
in Adolescents with Type1 Diabetes; Role of Parent-Child Conflicts
J.A. Malik, A.M. Delamater, H.M. Koot
Posters
P/087/FRI
The PedsQL in Type 1 Diabetes: Reliability and Validity of the
Pediatric Quality of Life Inventory Generic Core Scales and
Type 1 Diabetes Module.
P. Sand, M. Kljajic, G. Forsander
■ Poster Session VI
Psychosocial II
Chairs: Alan Delamater (United States), Hilary Hoey (Ireland)
P/088/FRI
Health-Related Quality of Life and Metabolic Control in
Children with Type 1 Diabetes Mellitus
H. Tahirovic, A. Toromanovic, E. Tahirovic
P/096/WED
Association of Family Structure and Nationality with
Processes and Outcomes of Care of Children and
Adolescents with Type 1 Diabetes in Belgium
K. Doggen, N. Debacker, V. Van Casteren, Iqecad Scientific
Steering Committee
P/089/FRI
Preference and Ease of Use of Novotwist® Versus Conventional Screw-thread Needles Among Children and Adolescents
with Diabetes
S.K. Lilleøre, G. Ter-Borch
P/097/WED
The Efficacy of a Group Therapy Program for Adolescents
with Elevated Ha1c Levels: Maintenance of Improvements in
Glycemic Control at 1-Year Follow-up
L.A. Kaminsky, M.N. Watts
P/090/FRI
DAWN Youth Survey: Family and Community Support for
Diabetes in India
A.K. Jhingan, D.G. Dalal, S. Kalra, R. Shetty, V. Garg, A. Juneja
P/098/WED
Differences in Personal Resources Between Insulin Pump
Users and Multiple Daily Injection (MDI) Users: A Pilot Study
in Adolescents with Type 1 Diabetes
J.P. Yi-Frazier, E. Alving, K. Farquharson, E.J.B. Buscaino,
S.L. Semana, M. Yaptangco, R.C. Bittner, C. Pihoker,
P/091/FRI
Exploring the Risk Factors for Eating Disturbances in Young
People with Type 1 Diabetes (T1D): Dysfunctional Perfectionism, Parental Eating Disturbances and Parental Criticism
E.L. Smith, S. Coker, C. Wilson, I. Hobbis, V. Datta, C.L. Acerini
P/092/FRI
Psychological and Medical Characteristics Associated with Disordered Eating in Australian Adolescents with Type 1 Diabetes.
H. D‘Emden, L. Holden, B. Mcdermott, M. Harris, K. Gibbons,
Y. Liu, A. Gledhill, T. Sadler, A. Cotterill
P/093/FRI
Dietary Behaviour of Adolescents with Type 1 Diabetes
L. Buysens, H. Dorchy
P/094/FRI
The Malay Version of Revised Summary of Diabetes
Self-Care Activities (SDSCA) is Reliable and Valid for
Use in Malaysian Children
M.Y. Jalaludin, F. Md. Zain, M.H. Mohd Hussain, J.Y.H. Hong,
Z. Hussein, F. Ismail, A. Bujang, J. Haniff
P/095/FRI
Self-care in Children with Type 1 Diabetes: Clarification and
Development of a Self-evaluation Tool
J. Pélicand, D. Charlier, I. Aujoulat
P/099/WED
Capillary Glucose Monitoring in Type 1 Diabetes Mellitus with
Children and Adolescent Does it Effect Metabolic Control?
G. Demir, D. Gökşen, G. Asar, Ö. Korkmaz, S. Darcan
P/100/WED
Parent-Reported Health-Related Quality of Life in Children
with Diabetes: Validity and Reliability of the Spanish
KINDL-R Questionnaire
M. Beléndez, M.C. Marín
P/101/WED
Growing up with Type 1 Diabetes: Exploring the Specific
Factors Which Impact on the Perceived Quality of Life in
Different Age Groups
J. Pélicand, M. Cahané
P/102/WED
Effects of Mental Health, Family Environment and Diabetes
Age-of-Onset on Adrenal Response to Psychosocial Stress in
Adolescents with Type 1 Diabetes Mellitus
D.J. Korczak, S. Madigan, K. Manassis, D. Daneman,
P/103/WED
Insulin ”Plus” Education in Type 1 Diabetes Children in India:
Transforming Helpless “Insulin Beggars” to Productive and
Self Supporting Citizens of the Nation ???
S. Geetha Rao, P. Krishnamurthy, U. Rangaraj, B. Naik,
T. Deepak, A. Sharda, S. Srikanta, Samatvam Endocrinology
Diabetes Center - Diabetes Collaborative Study Group
35
Posters
P/104/WED
Reliability and Validity of the Malay Translated Version of
Diabetes Quality of Life (DQoL) Questionnaire
M.Y. Jalaludin, F. Md. Zain, M.H. Mohd Hussain, J.Y.H. Hong,
Z. Hussein, F. Ismail, A. Bujang, J. Haniff
P/113/FRI
Impact of Individual Factors and Family Environment on
Metabolic Control of Children with Type 1 Diabetes Mellitus
F. Demirel, D. Tepe, I. Esen, N. Buber, H. Boztepe
P/105/WED
Measuring HbA1c in the Diabetes Outpatient Clinic.
P.-E. Kofoed, J. Thomsen, P. Jørgensen
P/114/FRI
The Significance and Consequence of Living with Type 1
Diabetes: Perceptions of Children and their Parent’s.
M. Marshall
P/106/WED
Pre and Post Marital Problems in People with Type 1
Diabetes in India
D. Yagnik, R. Shukla, B. Mohan, S. Bajpai, R. Saxena
P/115/FRI
Stress in the Mothers of Children with Early Onset Type 1
Diabetes and Learning Difficulty
R. Hannonen, J. Komulainen, R. Riikonen, T. Ahonen
■ Poster Session XVII
Psychosocial III
Chairs: Harry Dorchy (Belgium), Yasuko Uchigata (Japan)
P/116/FRI
Psychometric Properties of the Spanish Version of the
Diabetes Family Conflict Scale for Parents of Children and
Adolescents with Diabetes
M. Beléndez, M.C. Marín, G. Topa
P/107/FRI
Over 10 Program for Teens with Persistently Poorly Controlled
Type 1 Diabetes: Ongoing Challenges and Future Considerations.
R. Slater, M. Frank, M. Small, A. Newcombe, D. Daneman
P/117/FRI
Disease Perception by People with Type1 Diabetes
R. Shukla, D. Yagnik
P/108/FRI
Family Functioning (Cohesion and Adaptability), Emotional
Competences and Glycaemic Control in a Sample of Type 1
Diabetics Children
M.F. Housiaux, J. Zurstrassen, O. Luminet, H. Dorchy
■ Poster Session VII
Onset of Diabetes
Chairs: Leonardo Pinelli (Italy), Adriana Roussos (Argentina)
P/109/FRI
The Effect of Consulting via Internet on Fear of Hypoglycemia and Metabolic Control in Adolescents with Type 1
Diabetes
N.S. Celasin, Z. Basbakkal, G. Demir, D. Gökşen, S. Darcan
P/110/FRI
The Opinion of African Children with Diabetes about the
Support They Obtain from their Families
F.P.R. De Villiers, M.C. Segoe
P/111/FRI
Relationship Between Psychosocial Health, Health Related
Quality of Life, HbA1c and No Shows in Adolescents with
Type 1 Diabetes Mellitus
J.J.A. Van Leendert, E.A. Boogerd, J.A.E.M. Van Alfen-Van Der
Velden, M.C.C.H. Steeghs, E.E. Hartman, C.M. Verhaak
P/112/FRI
Poor Dietary Patterns in Adolescents with and without
Type 1 Diabetes
F.K. Bishop, D.M. Maahs, G. Spiegel, E.J. Mayer-Davis,
R.P. Wadwa
36
P/118/WED
Clinical Characteristics at Presentation of Type 1 Diabetes in
Children Aged Under 15 Years in Croatia
G. Stipancic, L. La Grasta Sabolic, A. Radica, V. Skrabic, S. Severinski
P/119/WED
Does Initial Glycated Haemoglobin A1c (HbA1c) Influence
Further Glycaemic Control in Type 1 Diabetes (T1DM) Children?
A. Chobot, J. Polanska, A. Gawron, M. Chumiecki, B. Echolc,
P. Jarosz-Chobot
P/120/WED
Onset Forms in Type 1 Diabetes Mellitus During 10 Years of
Folow Up in a Pediatric Diabetes Unit.
M.E. Andrés, M. Ferraro, P. Taberner, V. Jimenez, I. Strasnoy,
S. Barbeito, A. Franchello, O. Ramos
P/121/WED
Does Income Inequality Explain Geographical Differences in
Key Diabetes Indicators in Childhood?
D. Daneman
Posters
P/122/WED
Low 1,25-dihydroxy vitamin D levels in teens with new-onset
type 1 diabetes (T1D)
J.M. Drijvers, L.K. Volkening, B.M. Svoren, J.R. Wood, L.M. Laffel
P/130/FRI
Effects of Bay Leaves on Blood Glucose and Lipid Profiles on
the Patients with Type 1 Diabetes
A. Aljamal
P/123/WED
Revisiting the Accelerator Hypothesis: Does the Rate of
Weight Development Matter in Children with Genetic Risk
for Type 1 Diabetes (T1DM)?
B. Aschemeier, K. Semler, E. Keller On Behalf Of The Crescnet
-Team, T. Danne, O. Kordonouri
P/131/FRI
Beneficial Effects of Trigonella Foenum Graecum and its
Combination with Sodium Orthovanadate on Preventing
Metabolite Abnormalities in Heart, Muscle and Brain of
Alloxan Diabetic Rat
P. Kumar, A. Taha, R.K. Kale, N.Z. Baquer
P/124/WED
No Contribution from Vitamin D on the Increasing Trend of
Type 1 Diabetes
J. Svensson, S. Thorsen, H. Mortensen, M. Fenger, F. Pociot,
A. Linneberg
P/132/FRI
Appetite suppression with Caralluma fimbriata in patients
with Obese Type 1 Diabetes
B. Kalra, S. Kalra, N. Agrawal
P/125/WED
Continuous Rise in Incidence of Childhood Type 1 Diabetes
in Montenegro
M. Samardzic, N. Terzic
P/126/WED
Cold spot for Diabetes Incidence in Europe - 25 Years Follow Up
M. Kocova, E. Sukarova-Angelovska, N. Angelkova,
S. Spasevska, L. Kojic
P/127/WED
Relation between Type 1 Diabetes Mellitus and Atopy in
Childhood and Adolescence: Role of CD4+CD25+T cells
M.H. El Samahy, R.M. Matter, M.M. Ismail, M.S. El Sonbaty
■ Poster Session XVIII
New Treatment Options
Chairs: Ciril Krzisnik (Slovenia) , Jadranka Popovic (United
States)
P/128/FRI
Flexible Combination of Rapid Acting Insulin Analogue and
Regular Insulin in Prandial Treatment of Diabetes Improves
Overall Compensation.
D. Neumann, J. Jones, E. Mala,
P/129/FRI
Development of Insulin Detemir/Insulin Aspart Cross-reacting Antibodies Following Treatment with Insulin Detemir
in Type 1 Diabetes Patients over 104 Weeks
N. Thalange, A. Bereket, J. Larsen, L.C. Hiort, V. Peterkova
P/133/FRI
Similar Growth Velocities In Children with Type 1 Diabetes
(T1D) Treated with Glargine and NPH Suggests Lack of
Significant Clinical Effect of this Insulin Analog on the
Growth Plate IGF-1 Receptor.
R. Román, V. Gallardo, P. Martínez, X. Gaete, F. Cassorla, E. Codner
P/134/FRI
Ease of Use and Acceptability of a New Pen Device for the
Administration of Growth Hormone Therapy in Paediatric
Patients
S. Mikkelsen, G.S. Fuchs, T.K. Knudsen, A.-M. Kappelgaard
P/135/FRI
The Glycemic and Peak Incremental Indices of Honey, Sucrose and Glucose in Patients with Type 1 Diabetes Mellitus:
Effects on C-peptide Level—a Pilot Study
M. Abdulrhman, M.H. El Hefnawy, R. Hussei, A. Abou El-Goud
■ Poster Session VIII
Case Presentations
Chairs: Larry Deeb (United States), Sukran Darcan (Turkey)
P/136/WED
Type 1 Diabetes, Sickle Thalassemia in a Toddler, Case Report
in Saudi Arabia.
S. El Kholy
P/137/WED
Type 1 Diabetes Mellitus - Insulin Allergy – Crohn’s Disease K. Nagy, P. Bódi, P. Sipos
37
Posters
P/138/WED
An Egyptian Case of Congenital Hyperinsulinism of Infancy
Due to a Novel Mutation in KCNJ11 Encoding Kir6.2 and
Response to Octreotide
E. Sherif, A. Abdelmaksoud, N. Elbarbary, P. Njølstad,
P/146/FRI
Identification of a Novel Mutation in Five Patients with
Wolfram Syndrome Phenotype
C. Aloi, A. Salina, L. Pasquali, C. Russo, F. Lugani, G.M. Ghiggeri,
S. Toni, R. Lorini, G. D’Annunzio
P/139/WED
An Egyptian Case with Overlapping Features of Pigmented
Hypertrichotic Dermatosis with Insulin-Dependent Diabetes
(PHID) Syndrome and H Syndrome Due to a Novel Mutation
in SLC29A3
M.A. Salem, N.S. Elbarbary, J. Molnes, E. Tjora, M.A. Habib,
P.R. Njølstad,
P/147/FRI
HNF1B Gene Mutations Causing MODY 5 Phenotype
G. D‘Annunzio, A. Salina, C. Aloi, L. Pasquali, G.M. Ghiggeri, R. Lorini
P/140/WED
THE Wolcott-Rallison Syndrom : TWO NEW Moroccan Cases
Z. Imane, S. Amhager, N. Bennani, A. Balafrej
P/141/WED
A Case of Infant with Diabetes Due to Kir6.2 Mutation Switching from CSII to Oral Sulfonylureas
N. Nagano, T. Urakami, Y. Mine, H. Watanabe, A. Yoshida,
J. Suzuki, H. Saito, M. Ishige, S. Takahashi, H. Mugishima,
T. Yorifuji
P/142/WED
Epilepsia Partialis Continua (EPC) at Presentation of Type 1
Diabetes Mellitus with Diabetic Ketoacidosis (DKA) in a 1.5
Years Old Boy
V. Iotova, M. Zheleva, R. Ralcheva, V. Platikanov, B. Balev,
W. Mladenov, M. Moskova, B. Varbanova
P/143/WED
CSII Allows Desensitization and Diabetes Treatment in a
Type 1 Diabetic Child with Insulin Allergy
C. Hasselmann, C. Pecquet, E. Bismuth, C. Raverdy,
A. Sola-Gazagnes, J.-C. Carel, N. Tubiana-Rufi
■ Poster Session IXX
Diabetes Genetics, Immunology
Chairs: Gyula Soltesz (Hungary), Christos Bartsocas (Greece)
P/144/FRI
Mutational Analysis in Patients with a Clinical MaturityOnset Diabetes of the Young (MODY) Phenotype
A. Salina, C. Aloi, E. Calandra, F. Lugani, G.M. Ghiggeri,
G. D’Annunzio, R. Lorini
P/145/FRI
Early Onset of Type 1 Diabetes Mellitus is Associated With
p53 codon 72 polymorphism.
M.L. Manca Bitti, P. Saccucci, F. Capasso, S. Piccinini, F. Angelini,
A. Petrelli, E. Bottini, F. Gloria-Bottini
38
P/148/FRI
Newly Diagnosed Type 1 Diabetes is Associated to Intrafamilial Enterovirus Infections
A. Salvatoni, G. Bianchi, G. Maccari, G. Federico, A. Baj, A. Toniolo
P/149/FRI
C-peptide as Surrogate Therapeutic Marker for a Successful
Outcome.
P. Pozzilli
P/150/FRI
Vitamin D Insufficiency in a Brazilian Type 1 Diabetes Mellitus Pediatric Population
R. Savoldelli, M. Ybarra, F. Fontan, T. Della Manna,
H.C. Menezes-Filho, L. Steinmetz, D. Damiani
P/151/FRI
High Prevalence of Vitamin D Deficiency in a Subgroup of
Y. Yeshayahu, E.B. Sochett, S. Sud, F.H. Mahmud,
P/152/FRI
First Trimester Serum Cytokine Levels and the Development
of Autoimmune Disease in Offspring.
M. Fex, S. Björck, K. Lynch, C. Brundin, K. Marsal, D. Agardh, S.
Resic Lindehammer
P/153/FRI
Preparation, Distraction and Clinical Care of Children with
Multiple Islet Autoantibodies Participating in DiAPREV-IT,
the First Prevention Trial with Alum-GAD.
C. Nilsson, G. Hansson, H. Elding Larsson, For The Diaprev-It
Study Group
■ Poster Session IX
Diabetes from Developing Countries
Chairs: Toni Moran (United States), Hernan García (Chile)
P/154/WED
The Effectiveness of Photographic Educational Material on
Carbohydrate Counting for Adolescents with Diabetes
A.S. Gandolfo, A.A. Ferraro, D.V. Bastos, B.A.J. Makluf,
L.D.C.L. Neri, R.D. Savoldelli, T.D. Manna, D. Damiani
Posters
P/155/WED
HbA1c levels of Indonesia Diabetic Children with Intensive
Insulin Regiment
A. Girimoelyo, R. Purbasari, F. Soesanti, B. Tridjaja,
J.R. Batubara, A.B. Pulungan
P/156/WED
Diabetes Care for Resource Limited Settings [D4RLS]: Paradigm of Childhood / Insulin Dependent Diabetes in India
P. Krishnamurthy, S. Geetha Rao, U. Rangaraj, B. Naik,
P/157/WED
Diabetes Mellitus Education for Mothers, Part of Prevention
of Diabetes Mellitus for Children in Kediri, Indonesia.
M.J. Fero
P/158/WED
“Rationed SHBGM” – Limited Self Home Blood Glucose
Monitoring in Improving Metabolic Control in Economically
Disadvantaged Children with Type 1 Diabetes in India:
Discipline “Compensation” for Poverty.
S. Geetha Rao, P. Krishnamurthy, U. Rangaraj, B. Naik,
P/159/WED
Clinico-epidemiological Study of Type 1 Diabetes Mellitus in
Egyptian Children and Adolescents
M.A. Salem, A.A. Tantawy, M. Radwan, E. Mansour, I. El Nekhely, R.K. Abd El Raouf, M.H. El Samahy, E.M. Sherif, N.A. El
Beblawy, R.M. Matter, M. Abou El Asrar, A.A. Adly, A.A. Hamed
P/160/WED
The Challenges of Children with Diabetes West Nile Region
Arua-Uganda.
A.N. Joyo
■ Poster Session XX
Monogenic Diabetes
Chairs: Oddmund Sovik (Norway), Luis Castaño (Spain)
P/161/FRI
Infancy Onset Diabetes: A Monogenic or Autoimmune Form
of Diabetes?
M. Dirlewanger, C. Girardin, J.L. Blouin, V. Schwitzgebel
P/162/FRI
Review of Genetic Diabetes in an Irish Paediatric Diabetes
Centre
M. White, C. Costigan, D. Cody
P/163/FRI
Diabetes Autoantibodies can Discriminate MODY from Type
1 Diabetes
T.J. McDonald, K. Colclough, R. Brown, S. Ellard, A.T. Hattersley
P/164/FRI
Neonatal Diabetes Mellitus: A Clinical Analysis of 13 Cases.
X. Li, L. Liu, J. Cheng, W. Zhang
P/165/FRI
Neurodevelopmental Abnormalities in Children with
Neonatal Diabetes Due to KCNJ11 Mutations
R.E.J. Besser, O. Rubio-Cabezas, M. Shepherd, B.M. Shields,
S. Ellard, H. Curtis, A.T. Hattersley
P/166/FRI
Case Report: Permanent Neonatal Diabetes Mellitus Due to a
Novel Mutation in the INS Gene.
E. Petraikina, I. Garyaeva, E. Pronina, I. Rybkina, T. Mikhailova,
A. Timofeev, J. Tichanovich, A. Tiulpakov
P/167/FRI
De Novo whole GCK Gene Deletion not Detected by Gene
Sequencing, in a Boy with Phenotypic GCK Insufficiency.
N.H. Birkebaek, J. Vikre-Jorgensen, A.E. Sorensen, P.K. Jensen,
O. Pedersen, T. Hansen
P/168/FRI
DEND syndrome: Establishment of Good Glycemic Control
with Glyburide with Little Improvement in Cognitive Function.
M. Marinkovic, C. Demeterco-Berggren, S. Nichols, R. Haas,
K.L. Jones,
P/169/FRI
Severe Neonatal Infection in Wolcott Rallison Syndrome
E. Bismuth, M. Gerard, R. Blonde, J.-C. Carel, N. Tubiana-Rufi
■ Poster Session X
Pumps and Sensors I
Chairs: Nadia Tubiana (France), Rimante Dobrovolskiene
(Lithuania)
P/170/WED
Faster is Better: Investigating the Effect of a Novel Warming
Device on the Pharmacodynamics of Rapid Acting Insulin in
Youth with Type 1 Diabetes (T1D)
E. Cengiz, W.V. Tamborlane, J. Sherr, M. Martin, A.T. Steffen,
L. Carria, S.A. Weinzimer
39
Posters
P/171/WED
Improved Treatment Satisfaction Using Continuous
Subcutaneous Insulin Infusion Compared to Multiple Daily
Injections in Children at Onset of Type 1 Diabetes Mellitus
— a Five-year Follow-up Study
L. Skogsberg, J. Skogsberg, H. Fors
P/172/WED
Is Csii Superior to MDI in Everyday Life to Decrease Glucose
Variability when Using the Real Time Continuous Glucose
Monitoring System (RT-CGMS)?
S. Zucchini, M. Scipione, C. Balsamo, G. Maltoni, A. Rollo,
P. Di Stefano, A. Cicognani
P/173/WED
Insulin Pump Treatment, Increasing Prevalence and Better
Metabolic Outcomes in Danish Children and Adolescents
with Type 1 Diabetes.
B.S. Olsen, M.-L. Andersen, J. Johannesen, L. Lyngsøe, H. Rida,
B. Hertz, N. Birkebæk, J. Svensson, The Danish Study Group For
Diabetes In Childhood
P/174/WED
Insulin Pump Therapy Versus Multiple Injections in Young
Children with Diabetes: Comparison of Long-term Efficacy
R. Bonfanti, F. Meschi, M. Viscardi, A. Rigamonti, V. Biffi,
G. Frontino, R. Battaglino, V. Favalli, C. Bonura, G. Chiumello
P/175/WED
Can a Paediatric Insulin Pump Program be Successful in
Rural Practice?
P.W. Goss
P/176/WED
Evaluation of Continuous Glucose Monitoring in a Rural
Australian Paediatric Diabetes Program
P.W. Goss, M.A. Paterson
P/177/WED
High Quality of Life in Children and Psychological Wellbeing
in Mothers 12 Month After Diabetes Onset: Results of The
Paediatric ONSET-Trial of Sensor-enhanced CSII
K. Lange, R. Coutant, T. Danne, T. Kapellen, E. Pankowska,
B. Rami, B. Aschemeier, S. Bläsig, R. Hartmann, N. Krug,
E. Marquardt, K. Remus, O. Kordonouri
P/178/WED
Automated Overnight Closed-Loop Glucose Control in Young
Children with Type 1 Diabetes (T1D)
J. Allen, D. Elleri, M. Nodale, M.E. Wilinska, J.S. Mangat,
A.M. F. Larsen, C.L. Acerini, D.B. Dunger, R. Hovorka
40
■ Poster Session XXI
Pumps and Sensors II
Chairs: Natasa Bratina (Slovenia), Zdenek Sumnik (Czech Republic)
P/179/FRI
Acute Diabetes Complications and CSII Treatment
N. Zelinska, Y. Globa, L. Nifontova
P/180/FRI
Insulin Pump Applied to a 1600g Preterm Neonate Presenting Multiple Congenital Defects.
A. Galli-Tsinopoulou, E. Emmanouilidou, P. Karagianni,
M. Lithoxopoulou, I. Maggana, N. Nikolaidis
P/181/FRI
Adverse Events in Diabetic Patients on Continuous Subcutaneous Insulin Infusion (CSII)
J. Suzuki, A. Yoshida, H. Saito, M. Ishige, S. Takahashi, H. Mugishima
P/182/FRI
Insulin Pump Therapy in Children and Adolescents with
Type 1 Diabetes in Siberia
I.V. Osokina, G.U. Strelnikov
P/183/FRI
Influence of Insulin Pump-therapy on Chronic Diabetes
Complications in Children With DM 1 in Ukraine (Results
From 1 Year Follow-up Data).
N. Zelinska, Y. Globa, L. Nifontova
P/184/FRI
Continuous Subcutaneous Insulin Infusion (CSII) and
Multiple Daily Insulin Injections (MDI): Do These Treatments Affect Quality of Life? Results of Vipkids Study
V. Cherubini, R. Gesuita, A.M. Cester, M. Biagioni, M. Marigliano, A. Iannilli, A. Scaramuzza, I. Rabbone, F. Lombardo, N. Sulli,
R. Schiaffini, S. Tumini, R. Bonfanti, P. Frongia0, A. Franzese,
D. Iafusco, L. Pinelli, A. Salvatoni, S. Toni, F. Carle
P/185/FRI
Diabetes Mellitus During the First 6 Months of Life: Cumulative Experience from The Austrian/German DPV Register
M.H. Borkenstein, J. Grulich-Henn, K. Raile, T. Kapellen, J. Wolf,
S.E. Hofer, A. Hattersley, S. Ellard, R.W. Holl, For The Dpv Initiative
And The German Bmbf Competence Network Diabetes
P/186/FRI
The SWITCH study (Sensing With Insulin pump Therapy to
Control HbA1c). Design and Methods of a Randomized
Controlled Cross-over Trial on Sensor-augmented Insulin
Pump Efficacy in Type 1 Diabetes Sub-optimally Controlled
with Pump Therapy
I. Conget, T. Battelino, M. Giménez, H. Gough, J. Castañeda,
J. Bolinder, Switch Study Group
Posters
■ Poster Session XXI
Type 2 Diabetes in Children
Chairs: Robert Hoffman (United States), Maarten Reeser
(Netherlands)
P/187/WED
Health-Related Quality of Life of Overweight Preschool
Children
C. Ziegler, B. Aschemeier, A. Tewes, E. Marquardt, E. Sadeghian,
T. Danne, K. Lange
P/188/WED
Influence of the Polimorphism of KCNJ11, Encoding for the
Pancreatic Beta-cell Adenosine 5’-triphosphate-sensitive
Potassium Channel Subunit Kir6.2, on Birth Weight and
Auxological Parameters, Glucose, Insulin and Lipids Secretion in Prepubertal SGA Children.
M. Szalapska, R. Stawerska, M. Borowiec, W. Mlynarski,
K. Antosik, M. Hilczer, A. Lewinski
P/189/WED
Clinical and Metabolic Phenotype of 629 Obese Children and
Adolescents with Normal Glucose Tolerance, Impaired
Glucose Tolerance, and Type 2 Diabetes Mellitus
F. Ugrasbul, G. Babar, A.M. Sherman
P/190/WED
Assessment of Maternal Perceptions of Health Problems:
Type 2 Diabetes Risk Reduction Intervention
A.M. Patino-Fernandez, E. Pulgaron, J. Hernandez, J. Sanchez,
A.M. Delamater
P/191/WED
Clinical Characteristics in Children with Non-obese Type 2
Diabetes Detected by the Urine Glucose Screening Program
at Schools in the Tokyo Metropolitan Area
T. Urakami, M. Habu, N. Nagano, A. Yoshida, J. Suzuki, M.
Ishige, H. Saito, S. Takahashi, H. Mugishima
P/192/WED
D-dimer Levels in Type 1 and Type 2 Diabetic Children and
Adolescents; Relation to Microvascular Complications and
Dyslipidemia
M. El Asrar, A. Adly, E. El Hadidi
P/193/WED
Correlates of Treatment Patterns Among Youth with Type 2
Diabetes
C. Pihoker, A. Badaru, J. Talton, D. Casey, B. Linder, E. MayerDavis, W. Fujimoto, J. Lawrence, S. Marcovina, D. Dabelea, G.
Imperatore0, G. Klingensmith, Search For Diabetes In Youth
P/194/WED
Ketosis Prone African Type 2 Diabetes Does also Exist in Children
N. Falucar, G.C. Sophie, B. Elise, C.C. Jean, T.-R. Nadia
P/195/WED
Different Stages of Glucose Tolerance Alteration (Impaired
Fasting Glucose, Impaired Glucose Tolerance and Type 2
Diabetes Melltitus) in Obese Children and Adolescents
J. Argote Parolis, M.E. Licea Puig, F.C. Martínez,
R.M. González Suárez
P/196/WED
Features of the Clinical Course of Type 2 Diabetes in Children
and Teenagers
E.G. Michailova, A.V. Kulyashova
■ Poster Session XXII
Varia
Chairs: William Clarke (United States), Renata Lorini (Italy)
P/197/FRI
Transient Hiperglycemia during Induction Therapy in
Children with Acute Lymphoblastic Leukemia
L. Gaete, L. Caracotche, F. Miari, P. Silvina, M. Gutierrez, B. Galli,
V. Osta, L. Aversa, L. Trifone
P/198/FRI
Anthropometry, Metabolic Control in Type 1 Diabetes with
Celiac Disease
E. Faleschini, P. Pascolo, G. Tornese, G. Tonini
P/199/FRI
Clinical Symptoms of Celiac Disease in Children and
Adolescents with Type 1 Diabetes. Children’s Hospital of the
Holy Trinity of Córdoba.
M. Molinero De Rópolo, I.J. Kohn, C. Riga, N. Zanotti,
M.H. Nuñez, R.A. Furnes, M.L. Mignon
P/200/FRI
Characteristics of Celiac Disease (CD) in Patients with Type 1
Diabetes (DM1)
G.M. Lou-Francés, M. Rodríguez-Rigual, M.I. Pellicena,
M. Ferrer, L. Ros Mar, V. Giménez, A. Campos
P/201/FRI
Routine Screening for Celiac Disease Among Patients with
Diabetes
M. Rewers, E. Hoffenberg, G. Klingensmith, J. Simmons,
G. Eisenbarth, E. Liu
41
Posters
P/202/FRI
Limitations of Race and Ethnicity Classifications for
Pediatric Patients with Type 1 Diabetes: Early Results from a
Pilot Study
R. O‘Connor, A. Doorenbos, J. Yi-Frazier, J. Voss, A. Dobra, A.
Badaru, C. Pihoker
P/203/FRI
CF-related Diabetes (CFRD) in Pediatric Patients Compared to
Type-1-diabetes (T1DM): Analysis Based on the German /
Austrian DPV Register
K. Tzamouranis, A. Thon., K. Schaaf, M. Fritsch, E. FröhlichReiterer, H. Bartelt, R. Holl, The Dpv Initiative And The
German Bmbf Competence Network Diabetes
P/204/FRI
Transient Hyperglycemia During Induction Chemotherapy
in Children with Acute Lymphoblastic Leukemia
K. Flower, S. Kannan
P/205/FRI
High Day-to-day Variability in Carbohydrate Intake is
Associated with Increased Fluctuations in Plasma Glucose in
Children < 7 Years with T1DM but not with Higher HbA1c.
F. Sundberg, U. Cederholm, G. Forsander, M. Axelsen
42
Conference Venue & Exhibition Plan
First Floor
Main Entrance
Medtronic
Upper Hotel Lobby (part)
Foyer
Libertador
Exhibition &
Catering
Roche Art Contest
Roche
Wednesday only
Sanofi-aventis
Groupe
Elevator to the
Meeting Rooms,
Workshops &
Speakers Center
(Second Floor)
Bayer
Diabetes Care
Libertador C
Libertador B
Libertador A
Room Catalinas
Registration
Novo
Nordisk A/S
Eli Lilly and
Company
Main
Foyer
Exhibition
&
Catering
Exhibitor List
Bayer Diabetes Care
CUI.D.AR
Eli Lilly and Company
ISPAD
Medtronic
Novo Nordisk A/S
Roche
Sanofi-aventis Groupe
Room Retiro
ISPAD
Poster Exhibition
CUI.D.AR
Second Floor
E
D2
D1
C
B2
B1
A
A
B1
B2
C
D1
D2
E
Río de la Plata
Ombú 1
Ombú 2
Poncho
Martín Fierro 1
Martín Fierro 2
Gómez Losada - Speaker‘s Center
43
Pediatric Diabetes
The only journal exclusively devoted to the
science and care of childhood diabetes
2009
I m PA C T
FA C T o r
2.628
Don’t miss out on the top 10
most accessed articles of 2009!
l
l
l
l
l
l
l
l
l
l
Type 2 diabetes mellitus in the child and adolescent
AL Rosenbloom, JH Silverstein, Shin Amemiya et al
Continuous subcutaneous insulin infusion vs. multiple daily
injections in children with type 1 diabetes: a systematic
review and meta-analysis of randomized control trials
E Pankowska, M Błazik, P Dziechciarz et al
State of the world’s children with diabetes
Denis Daneman
Exercise in children and adolescents with diabetes
K Robertson, P Adolfsson, MC Riddell et al
Prolonged use of continuous glucose monitors in children
with type 1 diabetes on continuous subcutaneous insulin
infusion or intensive multiple-daily injection therapy
Diabetes Research in Children Network (DirecNet) Study Group
The metabolic syndrome in children and adolescents –
an IDF consensus report
Paul Zimmet, K George MM Alberti, Francine Kaufman et al
Insulin detemir is characterized by a more reproducible
pharmacokinetic profile than insulin glargine in children and
adolescents with type 1 diabetes: results from a randomized,
double-blind, controlled trial
Thomas Danne, Nicolin Datz, Lars Endahl et al
An overview of pediatric obesity
Warren WR Lee
Short-term metabolic and cardiovascular effects of metformin
in markedly obese adolescents with normal glucose tolerance
Tania S Burgert, Elvira J Duran, Rachel Goldberg-Gell
Full members of
ISPAD receive a
subscription as part
of their membership
Epidemiology of childhood type 2 diabetes and obesity
Jonathan Shaw
To access these articles or for further information visit www.pediatricdiabetesjournal.com
44
October 27th – 30th, 2010 scientifi
| Buenos Aires,
Argentina
Communicating
c advances
in a clinical context
Endocrine Development
Editor: P.-E. Mullis
Vol. 18
Current Indications
for Growth
Hormone Therapy
w w w . k a r g e r. c o m / e n d e v
2nd, revised edition
Editor
P.C. Hindmarsh
Contents
Preface: Hindmarsh, P.C.
Clinical Trials: Planning and Analysis:
Farewell, V.T.; Cook, R.J.
Endocrine Development, Vol. 18
Current Indications for
Growth Hormone Therapy
Editor: Hindmarsh, P.C. (London)
VIII + 130 p., 5 fig., 18 tab., hard cover, 2010
CHF 124.– / EUR 88.50 / USD 124.00
ISBN 978–3–8055–9194–2
e-ISBN 978–3–8055–9195–9
Endocrine Development
Editor: P.-E. Mullis
Vol. 19
Adipose
Tissue Development
From Animal Models to
Clinical Conditions
Editors
C. Levy-Marchal
L. Pénicaud
The Evidence Base for Growth Hormone
Effectiveness in Children: Kelnar, C.J.H.
Safety of Recombinant Human Growth
Hormone: Carel, J.-C.; Butler, G.
Diagnosis of Growth Hormone
Deficiency: Webb, E.A.; Dattani, M.T.
Richmond, E.; Rogol, A.D.
Adipose Tissue Development
From Animal Models to Clinical Conditions
Contents
Capeau, J.; Magré, J.; Caron-Debarle, M.;
Lagathu, C.; Antoine, B.; Béréziat, V.;
Lascols, O.; Bastard, J.-P.; Vigouroux, C.
The Emergence of Adipocytes:
Endocrine Development, Vol. 19
Adipose Tissue Development
Editors: Levy-Marchal, C. (Paris); Pénicaud, L. (Dijon)
X + 96 p., 11 fig., 3 tab., hard cover, 2010
CHF 98.– / EUR 72.50 / USD 98.00
ISBN 978–3–8055–9450–9
e-ISBN 978–3–8055–9451–6
Please send:
�
�
copy/ies: Current Indications for
CHF 124.– / EUR 88.50 / USD 124.00
ISBN 978–3–8055–9194–2
copy/ies: Adipose Tissue Development
CHF 98.– / EUR 72.50 / USD 98.00
ISBN 978–3–8055–9450–9
Prices subject to change
EUR price for Germany, USD price for USA only
Biological Determinants ofResponsiveness to Growth Hormone:
Pharmacogenomics and Personalized
Medicine: Mullis, P.-E.
Clinical Considerations in Using Growth
Hormone Therapy in Growth Hormone
Deficiency: Ranke, M.B.
Current Indications for Growth Hormone
Therapy for Children and Adolescents:
GH Use in the Transition of Adolescence
to Adulthood: Mauras, N.
Preface: Levy-Marchal, C.
Human Lipodystrophies: Genetic and
Acquired Diseases of Adipose Tissue:
HOR MONE
RE SE ARCH I N
PÆDIATRIC S
Order Form
Current Indications for
Laharrague, P.; Casteilla, L.
Adipose Tissue and the Reproductive
Axis: Biological Aspects: Hausman, G.J.;
Barb, C.R.
Unraveling the Obesity and Breast Cancer
Links: A Role for Cancer-Associated
Adipocytes?: Dirat, B.; Bochet, L.;
Escourrou, G.; Valet, P.; Muller, C.
Early Determinants of Obesity: Ong, K.K.
Metabolic Syndrome in Childhood –
Causes and Effects: Weiss, R.
Pathophysiology of Insulin Resistance in
Small for Gestational Age Subjects:
A Role for Adipose Tissue?: Beltrand, J.;
Meas, T.; Levy-Marchal, C.
The Neural Feedback Loop between the
Brain and Adipose Tissues: Pénicaud, L.
Keep up-to-date
on basic and clinical research:
www.karger.com/hrp
Payment:
(Postage and handling free with prepayment)
Please charge to my credit card
� American Express � Diners
� Visa
� Euro-, MasterCard
Fax: +41 61 306 12 34
S. Karger AG, P.O. Box, CH–4009 Basel (Switzerland)
E-Mail orders@karger.ch, www.karger.com
Name/Address:
Card No.:
Exp. date:
CVV/CVC:
(3 digits in the signature field on the back of Visa and MasterCard)
� Check enclosed
� Please bill me
Orders may be placed with any bookshop, subscription agency,
directly with the publisher or through a Karger distributor.
Date:
Signature:
45
KI 10690
Social Events & Tours
Opening Ceremony & Welcome Reception
Wednesday October 27th, 2010
Besides the opening addresses, the Opening Ceremony will
feature a dance performance by the Escuela de Danzas Aída
V. Mastrazzi.
Directora de la Escuela: Fabiana Bezenzette
Directora del Ballet: Silvana Sapia
Co-Dirección: Marcela Alvarez y María Elena Anllo
Asistente: Romina Mancini
Folklore, All over Argentina
1. Danza de cintas (Coya) / 2. Malambo Sureño (La Pampa)
3. Gauchito catamarqueño (Catamarca) / 4. Candombe
(Buenos Aires) / 5. Chamamé y polca (Corrientes) / 6. Zamba
(Santiago del Estero) / 7. Chacarera y Malambo (Santiago del
Estero)
Tango across time
1. Desde el alma (vals) / 2. Danzarin (tango) / 3. Tango /
4. Milonga / 5. Libertango / 6. Escucha…Siénteme (Contemporáneo)
18.30 - 20.00
Social Afternoon at Opera Pampa
Thursday October 28th, 2010
Enjoy an epic tour through the „gaucho“ adventure and
traditions since the arrival of the horse to America to the
birth of the Argentine Nation. You will discover Argentinean
history, the beginnings of a nation and its traditions in an
extraordinary and unique show. Before the show you can
use the opportunity to take tango lessons and enjoy the
atmosphere of Opera Pampa. After the show, you will taste
famous Argentinean beef grilled in a typical Gaucho style.
15.30 - 20.00
Shuttle buses depart at 15.30 from the Sheraton Buenos Aires
Hotel & Convention Center.
Society‘s Evening at Palacio San Miguel
Friday October 29th, 2010
The Society‘s Evening will be an elegant get-together and social
highlight of ISPAD 2010. Held in one of the nobles ventures, a
building that represents a period of Argentinean history and
culture and the style of the time. The evening will start with a
reception and afterwards the ISPAD prizes will be awarded to
the nominees. It will be an evening full of entertainment, food
and music, and an excellent opportunity for everybody to meet
and get to know other conference participants.
19.30 - midnight
Shuttle buses depart at 19.00 from the Sheraton Buenos Aires
Hotel & Convention Center.
Social Tours
All tours will start from the lobby of the Sheraton Buenos
Aires Hotel & Convention Center. Please make sure to be
there in time and that you have your tour voucher available
which has to be bought in advance.
Buenos Aires City Tour
Thursday, October 28th, 2010 (09.30 - 12.30)
Personalities Buenos Aires
Eva Peron, A Woman Who Changed History
Thursday, October 28th, 2010 (14.00 - 18.00)
Buenos Aires Art Tour
Friday, October 29th, 2010 (09.30 - 12.30)
Gaucho´s Party
La Candelaria Ranch
Saturday, October 30th, 2010 (09.00 - 17.00)
La Plata City
A Dream City
Saturday, October 30th, 2010 (09.30 - 14.30)
San Telmo Flea Market
Sunday, October 31st, 2010 (09.30 - 12.30 or 14.00 - 17.00)
Delta with Lunch
Sunday, October 31st, 2010 (09.30 - 15.30)
46
City & Hotel Map
City & Hotel Map
The map below indicates the location of the conference center, various social function locations as well as the hotels.
Key
H
V
Hotels
E
Congress Center
Society‘s Evening
Ma
rtí
n
es
Air
u e nos
a
Sa
nM
art
ín
Río d
Ma
ipú
al
Av. R
os
Rá
bida
Bas
avilb
aso
Av
en
ida
Cerrit
o
Av. 9 de Ju lio
Sa
n
ta
Río de la Pla
La
Av.
a
Río de la Plat
Bolívar
so
Juana Man
Puerto Madero
Este
Tranvía del
Adolfo Alsina
Balcarce
Perú
Chacabuco
1
ini
Olga Cossent
Bouchard
Alem
Av. Leandro N.
Reconquista
Catedral
Av. Rivadavi a
Perú
Plaza de Mayo
Bolívar
Piedras
Lima
Tacuarí
Salta
Solis
San José
ata
a Pl
au de Justo
More
Alicia
Corrientes
itre
Bartolomé M
Perú
Piedras
Bouchard
Bouchard Bouchard
25 de Mayo
lem
andro N. A
Av. Le
Reconquista
San Martín
Florida
Av. Rivadavia
Lima Avenida de Mayo
en
Hipólito Yrigoy
ista
Reconqu
San Martín
C
Libertad
Sáenz Peña
Lavalle
tes
Avenida Corrien
rón
Domingo Pe
Bartolomé Mitre
Maipú
E
eral Juan
Teniente Gen
so
Cecilia Grier n
Córdoba
6Leandro N. Alem
7
Sarmiento
Esmeralda Esmeralda
Av. 9 de Julio
Carlos Pellegrini
Libertad
Talcahuano
Uruguay
Av. Rivadavia
Congreso
Florida
8
e
Bartolomé Mitr
Bartolomé Mitre
Tucumán
Diagonal Norte
Sarmiento
Paraná
Rodríguez Peña
Av. Callao
Domingo Perón
eneral Juan
Teniente G
9 de Julio
Carabelas
San Nicolás
Rectorado
UBA
s
Avenida Corriente
Carlos Pellegrini
Cerrito
Ayacucho
Uruguay
rientes
Avenida Cor
Callao (B)
Lavalle
Lavalle
el
Paraguay
Av. Córdoba
Maipú
Lavalle
Lavalle
d
B
us
ueb
Buq
s
Tres Sargento
Viamonte
Lavalle
P lat
5
Maipú
Lavalle
Tribunales
Libertad
NH Latino
Maipú
10
Montevideo
Riobamba
Tucumán
3
Av. Córdoba
Suipacha
Uruguay
n Tucumán
cumán Tucumá
Tucumán Tu
Marcelo T. de Alvear
Esmeralda
NH Lancaster
9
Av. 9 de Julio
Av. 9 de Julio
Viamonte
Viamonte
Viamonte
General San Martín
Paraguay
Av. Córdoba
Cerrito
Av. Callao
Paraná
NH Jousten
8
Suipacha
Carlos Pellegrini
Libertad
Talcahuano
Av. Córdoba
D
Av. Córdoba
A
Libertad
Uruguay
a
Rodríguez Peñ
Paraguay
7 CallaoNH
(D) Florida
Sarmiento
de Alvear
Marcelo T.
Alvear
Marcelo T. dePlaza
Howard Johnson
Florida
NH Crillón
6
Cerrito
Paraná
5
4
Av. Santa Fe
Howard Johnson Plaza Florida
4
Arenales
Arenales
2
V
E
Sheraton Buenos Aires
Av. Santa Fe
Colegio
Carlos
Pellegrini
B
Libertad
Pa
re
ra
on
te
vi
de
o
Pe
ña
Ro
dr
íg
ue
z
Arenales
Retiro
m
. Ale
oN
ndr
Lea
Av.
Av. Callao
al
Juncal
Esmeralda
3
Av. 9 de Julio
Arenales
Colegio
Mallinckrodt
e
ad
om
ton
Au
Sheraton
Buenos Aires
Junc
Juncal
ad
Ciu
2
M
la
de
Río
NH City and Tower
De
lL
ibe
rta
do
r
ntina
Arge
tida
ntár
Av. A
1
M
el
o
Arroyo
ro
ade
oM
ard
Edu
Av.
Hotel
Esmeralda
#
de
Av
en
id
a
Suipacha
Ro
dr
íg
ue
z
Pe
ña
Al
ve
ar
G
ui
do
Talcahuano
Juncal
Ló
pe
z
Cerrito
Pe
ña
Vi
ce
nt
e
Carlos Pellegrini
A.
Pa
ch
ec
o
es
Jo
sé
Ay
ac
uc
ho
Palacio San Miguel
Suipacha 84
C1008AAB
Buenos Aires
200m
47
ISPAD 2011 Miami
48
October 19th – 22nd
“It helps to share my feelings with other children like me.”
INTRODUCING a new Conversation Map™ education tool for children
with type 1 diabetes and their families
Fun. Engaging. Inspiring. These are just a few of the reactions you can expect from participants
that experience our latest education tool, Living in a Family With Type 1 Diabetes. This new tool
helps address the emotional and psychological aspects of this disease and provides support
through this challenging time.
Visit us at the Lilly booth or contact your Lilly representative to learn more about the latest addition
to our Diabetes Conversations programme.
www.diabetes.healthyi.com
Created by
In collaboration with
Sponsored by
49
Solutions for every step of childhood.
THURSDAY, OCTOBER 28
Breakfast Symposium at 7:30 a.m.
Lunch Workshop at 12:30 p.m.
Visit our lunch workshop to learn how the Accu-Chek® Combo bolus advisor
supports CSII therapy in children.
The Accu-Chek Combo system, with its smart features, greatly supports children on CSII
and their parents. It also eases the transfer of responsibility from parent to child.
• Integrated bolus advisor for tighter control of postprandial blood glucose levels.
• The Accu-Chek® Performa Combo handheld lets the insulin pump be remotely operated:
by a parent or caregiver for a small child or discreetly by a teenager out with friends.
Experience what’s possible.
To learn more about the Accu-Chek Combo system, come see us at booth no. 8 at ISPAD 2010
in Buenos Aires from October 27 to 30.
ACCU-CHEK, ACCU-CHEK SPIRIT COMBO, COMBO and PERFORMA COMBO are
trademarks of Roche. The Bluetooth word mark and logos are registered trademarks owned
by Bluetooth SIG, Inc., and any use of such marks by Roche is under license. © 2010 Roche.
www.accu-chek.com
Roche Diagnostics GmbH
Sandhofer Straße 116
D-68298 Mannheim, Germany
50

- ispad 2010

Transcription

Similar documents

Education

ARC factsheet Special Research Initiative for Type 1 Juvenile

Tim McGraw has a challenge for you.

NIDDK Medical Student Research Program in Diabetes and Obesity

Diabetes, Type 1

Living with diabetes

Summary of University of Surrey Academic F2 projects 2012-15

File - RAP Dufferin-Peel (Retired Administrative Personnel)

By Quisa Foster - Cascade United Methodist Church

Read full article - West Feliciana Parish Hospital